var title_f19_39_20080="TB pneumonia";
var content_f19_39_20080=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Expansile pneumonia caused by tuberculosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 2-year-old toddler, infected by his mother, has an expansile pneumonia caused by tuberculosis and, perhaps, a secondary infection. The child presented with high fever, cough and weight loss. The clinical symptoms improved with conventional antibiotics, but cultures of the gastric aspirates grew",
"    <em>",
"     Mycobacterium tuberculosis",
"    </em>",
"    . A subsequent CT scan of the chest revealed extensive right-sided hilar adenopathy with obstruction of the main bronchus to the right upper lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey R Starke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20080=[""].join("\n");
var outline_f19_39_20080=null;
var title_f19_39_20081="Erythrocyte sedimentation rate in renal disease";
var content_f19_39_20081=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Erythrocyte sedimentation rate in renal disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20081/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20081/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20081/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20081/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20081/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20081/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/39/20081/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The erythrocyte sedimentation rate (ESR) is elevated (greater than 25",
"    <span class=\"nowrap\">",
"     mm/h",
"    </span>",
"    by the Westergren method) in almost all patients with the nephrotic syndrome or end-stage renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20081/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Two-thirds of patients have an ESR above 60",
"    <span class=\"nowrap\">",
"     mm/h,",
"    </span>",
"    while 20 percent have extreme elevations to above 100",
"    <span class=\"nowrap\">",
"     mm/h,",
"    </span>",
"    a level usually associated with disorders such as infection, cancer (particularly if metastatic), or collagen vascular diseases such as temporal arteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20081/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=see_link\">",
"     \"Acute phase reactants\"",
"    </a>",
"    .) The elevation in ESR is not affected by hemodialysis as the pre- and post-dialysis values are similar [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20081/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is likely that plasma factors, particularly increased levels of fibrinogen, are responsible for the elevation in ESR. Anemia and hypocalcemia do not appear to play a role and the ESR is not lowered by dialysis. A direct relation between the degree of proteinuria and the ESR has been noted in patients with glomerular disease in which the ESR was approximately 10 times the daily rate of protein excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20081/abstract/5\">",
"     5",
"    </a>",
"    ]. How this might occur is not clear.",
"   </p>",
"   <p>",
"    The frequent elevation in ESR in renal insufficiency or the nephrotic syndrome is important clinically, because this finding alone is not an indication to evaluate a patient for an underlying systemic disorder. This issue becomes important in a condition such as membranous nephropathy in which a minority of patients has an associated malignancy. Occult malignancy should be excluded if the patient has some suggestive finding such as weight loss, heme-positive stools, or unexplained anemia, but not an isolated increase in ESR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link\">",
"     \"Causes and diagnosis of membranous nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29238127\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The erythrocyte sedimentation rate (ESR) is elevated in almost all patients with the nephrotic syndrome or end-stage renal disease.",
"     </li>",
"     <li>",
"      This finding alone is not an indication to evaluate a patient for an underlying systemic disorder.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20081/abstract/1\">",
"      Bathon J, Graves J, Jens P, et al. The erythrocyte sedimentation rate in end-stage renal failure. Am J Kidney Dis 1987; 10:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20081/abstract/2\">",
"      Shusterman N, Kimmel PL, Kiechle FL, et al. Factors influencing erythrocyte sedimentation in patients with chronic renal failure. Arch Intern Med 1985; 145:1796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20081/abstract/3\">",
"      Arik N, Bedir A, G&uuml;naydin M, et al. Do erythrocyte sedimentation rate and C-reactive protein levels have diagnostic usefulness in patients with renal failure? Nephron 2000; 86:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20081/abstract/4\">",
"      Sox HC Jr, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986; 104:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20081/abstract/5\">",
"      Liverman PC, Tucker FL, Bolton WK. Erythrocyte sedimentation rate in glomerular disease: association with urinary protein. Am J Nephrol 1988; 8:363.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7191 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20081=[""].join("\n");
var outline_f19_39_20081=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29238127\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29238127\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=related_link\">",
"      Acute phase reactants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=related_link\">",
"      Causes and diagnosis of membranous nephropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20082="Saddle nose deformity";
var content_f19_39_20082=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    \"Saddle nose\" deformity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 297px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This \"saddle nose\" deformity developed as a complication of a nasal septal abscess in childhood.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: DeWeese, DD, Saunders, WH. Textbook of Otolaryngology, 4th ed, Mosby, St. Louis 1973. Copyright &copy; 1973 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20082=[""].join("\n");
var outline_f19_39_20082=null;
var title_f19_39_20083="Patient information: Exercise (The Basics)";
var content_f19_39_20083=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?8/15/8434\">",
"         Patient information: Activity during pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/22/9571\">",
"         Patient information: Arthritis and exercise (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/56/4994\">",
"         Patient information: Groin strain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/3/1074\">",
"         Patient information: Hamstring injury (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/37/8786\">",
"         Patient information: Metatarsalgia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/0/39938\">",
"         Patient information: Muscle strain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/58/35746\">",
"         Patient information: Osteoporosis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/10/18594\">",
"         Patient information: Patellofemoral pain syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/49/16147\">",
"         Patient information: Treatment for type 2 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/52/31554\">",
"         Patient information: Weight loss treatments (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/62/28645\">",
"         Patient information: Arthritis and exercise (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/37/36436\">",
"         Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/42/7844\">",
"         Patient information: Exercise (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/54/33635\">",
"         Patient information: High blood pressure in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/49/25366\">",
"         Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/5/33876\">",
"         Patient information: Weight loss treatments (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Exercise (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/exercise-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H27849549\">",
"      <span class=\"h1\">",
"       What are the benefits of exercise?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Exercise has many benefits. It can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Burn calories, which helps people lose weight",
"       </li>",
"       <li>",
"        Help control blood sugar levels in people with diabetes",
"       </li>",
"       <li>",
"        Lower blood pressure, especially in people with high blood pressure",
"       </li>",
"       <li>",
"        Lower stress and help with depression",
"       </li>",
"       <li>",
"        Keep bones strong, so they don&rsquo;t get thin and break easily",
"       </li>",
"       <li>",
"        Lower the chance of dying from heart disease",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849556\">",
"      <span class=\"h1\">",
"       What are the main types of exercise?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are 3 main types of exercise. They are:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Aerobic exercise &ndash; Aerobic exercise raises a person&rsquo;s heart rate. Examples of aerobic exercise are walking, running, or swimming.",
"       </li>",
"       <li>",
"        Resistance training &ndash; Resistance training helps make your muscles stronger. People can do this type of exercise using weights, exercise bands, or weight machines.",
"       </li>",
"       <li>",
"        Stretching &ndash; Stretching exercises help your muscles and joints move more easily.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      It&rsquo;s important to have all 3 types of exercise in your exercise program. That way, your body, muscles, and joints can be as healthy as possible.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849563\">",
"      <span class=\"h1\">",
"       Should I talk to my doctor or nurse before I start exercising?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have not exercised before or have not exercised in a long time, talk with your doctor or nurse before you start a very active exercise program.",
"     </p>",
"     <p>",
"      If you are likely to have heart disease, your doctor or nurse might recommend that you have an exercise test before you start an exercise program. But most people do not need an exercise test before they start an exercise program.",
"     </p>",
"     <p>",
"      When you start an exercise program, start slowly. For example, do the exercise at a slow pace or for a few minutes only. Over time, you can exercise faster and for longer periods of time.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849570\">",
"      <span class=\"h1\">",
"       What should I do when I exercise?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Each time you exercise, you should:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Warm up &ndash; Warming up can help keep you from hurting your muscles when you exercise. To warm up, do a light aerobic exercise (such as walking slowly) or stretch for 5 to 10 minutes.",
"       </li>",
"       <li>",
"        Work out &ndash; During a workout, you can walk fast, swim, run, or use an exercise machine, for example. You should also stretch all of your joints, including your neck, shoulders, back, hips, and knees. At least 2 times a week, you can add resistance training exercises to your workout.",
"       </li>",
"       <li>",
"        Cool down &ndash; Cooling down helps keep you from feeling dizzy after you exercise and helps prevent muscle cramps. To cool down, you can stretch or do a light aerobic exercise for 5 minutes.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849577\">",
"      <span class=\"h1\">",
"       How often should I exercise?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors recommend that people exercise at least 30 minutes a day, on 5 or more days of the week.",
"     </p>",
"     <p>",
"      If you can&rsquo;t exercise for 30 minutes straight, try to exercise for 10 minutes at a time, 3 or 4 times a day.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849584\">",
"      <span class=\"h1\">",
"       When should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have any of the following symptoms when you exercise, stop exercising and call your doctor or nurse right away:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain or pressure in your chest, arms, throat, jaw, or back",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Feeling like your heart is fluttering or racing very fast",
"       </li>",
"       <li>",
"        Feeling dizzy or faint",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849591\">",
"      <span class=\"h1\">",
"       What if I don&rsquo;t have time to exercise?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people have very busy lives and might not think that they have time to exercise. But it&rsquo;s important to try to find time to exercise, even if you are tired or work a lot. Exercise can increase your energy level, which might even help you get more work done.",
"     </p>",
"     <p>",
"      On days when you really can&rsquo;t find time to exercise, there are ways that you can be more active. For example, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Take the stairs instead of the elevator",
"       </li>",
"       <li>",
"        Park in a parking space that is farther away from the door",
"       </li>",
"       <li>",
"        Take a longer route when you walk from 1 place to another",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849598\">",
"      <span class=\"h1\">",
"       What else should I do when I exercise?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To exercise safely and avoid problems, be sure to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Drink fluids during and after exercising (but drinks should not have caffeine in them)",
"       </li>",
"       <li>",
"        Avoid exercising outside if it is too hot or cold out",
"       </li>",
"       <li>",
"        Wear layers of clothes, so that you can take clothes off if you get too hot",
"       </li>",
"       <li>",
"        Wear shoes that fit well and support your feet",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H27849605\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/22/9571?source=see_link\">",
"       Patient information: Arthritis and exercise (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/52/31554?source=see_link\">",
"       Patient information: Weight loss treatments (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/49/16147?source=see_link\">",
"       Patient information: Treatment for type 2 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/37/8786?source=see_link\">",
"       Patient information: Metatarsalgia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/0/39938?source=see_link\">",
"       Patient information: Muscle strain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/10/18594?source=see_link\">",
"       Patient information: Patellofemoral pain syndrome (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/56/4994?source=see_link\">",
"       Patient information: Groin strain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=see_link\">",
"       Patient information: Osteoporosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/15/8434?source=see_link\">",
"       Patient information: Activity during pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/3/1074?source=see_link\">",
"       Patient information: Hamstring injury (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/42/7844?source=see_link\">",
"       Patient information: Exercise (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"       Patient information: Arthritis and exercise (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33876?source=see_link\">",
"       Patient information: Weight loss treatments (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/37/36436?source=see_link\">",
"       Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/54/33635?source=see_link\">",
"       Patient information: High blood pressure in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"       Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?19/39/20083?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16159 Version 6.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-F1B7A60FFB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20083=[""].join("\n");
var outline_f19_39_20083=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849549\">",
"      What are the benefits of exercise?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849556\">",
"      What are the main types of exercise?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849563\">",
"      Should I talk to my doctor or nurse before I start exercising?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849570\">",
"      What should I do when I exercise?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849577\">",
"      How often should I exercise?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849584\">",
"      When should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849591\">",
"      What if I don&rsquo;t have time to exercise?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849598\">",
"      What else should I do when I exercise?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27849605\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/15/8434?source=related_link\">",
"      Patient information: Activity during pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=related_link\">",
"      Patient information: Arthritis and exercise (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/22/9571?source=related_link\">",
"      Patient information: Arthritis and exercise (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/37/36436?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/42/7844?source=related_link\">",
"      Patient information: Exercise (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/56/4994?source=related_link\">",
"      Patient information: Groin strain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/3/1074?source=related_link\">",
"      Patient information: Hamstring injury (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/54/33635?source=related_link\">",
"      Patient information: High blood pressure in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/37/8786?source=related_link\">",
"      Patient information: Metatarsalgia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/0/39938?source=related_link\">",
"      Patient information: Muscle strain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/58/35746?source=related_link\">",
"      Patient information: Osteoporosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=related_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/10/18594?source=related_link\">",
"      Patient information: Patellofemoral pain syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/49/16147?source=related_link\">",
"      Patient information: Treatment for type 2 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33876?source=related_link\">",
"      Patient information: Weight loss treatments (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/52/31554?source=related_link\">",
"      Patient information: Weight loss treatments (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20084="Flow T cell ALL";
var content_f19_39_20084=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83244&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 635px\">",
"   <div class=\"ttl\">",
"    Flow cytometric histograms in T cell acute lymphoblastic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 615px; height: 409px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow cytometric histograms show that the tumor cells react only to CD7 and CD34 with low percentages of CD3/CD4 and CD3/CD8. CD5, CD10, and CD19 are negative.",
"    <div class=\"footnotes\">",
"     SS: side scatter; PC5: phycoerythrin-cyanin 5; ECD: phycoerythrin-Texas Red; PE: phycoerythrin; RD1: rhodamine; FITC: fluorescein isothiocyanate.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sun T. Clinical application. In: Flow Cytometry, Immunochemistry, and Molecular Genetics for Hematologic Neoplasms, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20084=[""].join("\n");
var outline_f19_39_20084=null;
var title_f19_39_20085="Recombinant human growth hormone (somatropin): Patient drug information";
var content_f19_39_20085=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Recombinant human growth hormone (somatropin): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/54/12137?source=see_link\">",
"     see \"Recombinant human growth hormone (somatropin): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/61/3032?source=see_link\">",
"     see \"Recombinant human growth hormone (somatropin): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F222357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Genotropin Miniquick&reg;;",
"     </li>",
"     <li>",
"      Genotropin&reg;;",
"     </li>",
"     <li>",
"      Humatrope&reg;;",
"     </li>",
"     <li>",
"      Norditropin FlexPro&reg;;",
"     </li>",
"     <li>",
"      Norditropin&reg; NordiFlex&reg;;",
"     </li>",
"     <li>",
"      Nutropin AQ Pen&reg;;",
"     </li>",
"     <li>",
"      Nutropin AQ&reg;;",
"     </li>",
"     <li>",
"      Nutropin AQ&reg; NuSpin&trade;;",
"     </li>",
"     <li>",
"      Nutropin&reg;;",
"     </li>",
"     <li>",
"      Omnitrope&reg;;",
"     </li>",
"     <li>",
"      Saizen&reg;;",
"     </li>",
"     <li>",
"      Serostim&reg;;",
"     </li>",
"     <li>",
"      Tev-Tropin&reg;;",
"     </li>",
"     <li>",
"      Zorbtive&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F222358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Humatrope&reg;;",
"     </li>",
"     <li>",
"      Norditropin Simplexx;",
"     </li>",
"     <li>",
"      Nutropin AQ Pen&reg;;",
"     </li>",
"     <li>",
"      Nutropin AQ&reg; NuSpin&trade;;",
"     </li>",
"     <li>",
"      Nutropin&reg;;",
"     </li>",
"     <li>",
"      Nutropin&reg; AQ;",
"     </li>",
"     <li>",
"      Omnitrope&reg;;",
"     </li>",
"     <li>",
"      Saizen&reg;;",
"     </li>",
"     <li>",
"      Serostim&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691864",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat growth hormone deficiency.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat short bowel syndrome.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691379",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help you gain weight.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702244",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to human growth hormone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703443",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Brain tumor, cancer, diabetic eye disease, illness shortly after open heart or belly surgery, many injuries from a crash, lung disease, or sleep apnea.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3432324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a history of cancer, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are overweight, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697916",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698247",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle or joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritated pancreas.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       More trips to the bathroom, more thirst, or weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use if solution changes color.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11494 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-33CB703E27-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20085=[""].join("\n");
var outline_f19_39_20085=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222357\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F222358\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029788\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029787\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029792\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029793\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029795\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029790\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029791\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029796\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029797\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/54/12137?source=related_link\">",
"      Recombinant human growth hormone (somatropin): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/61/3032?source=related_link\">",
"      Recombinant human growth hormone (somatropin): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20086="MRI of the airway in a child with OSA";
var content_f19_39_20086=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRI of the airway in a child with obstructive sleep apna",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 404px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T1-weighted midsagittal and axial magnetic resonance&nbsp;imaging (MRI)&nbsp;of a control subject (C) and a subject with&nbsp;obstructive sleep apnea&nbsp;(OSA). Note that the&nbsp;subject with OSA has a narrow nasopharyngeal (top right) and oropharyngeal (lower right) airway.",
"    <div class=\"footnotes\">",
"     C: control; OSAS: obstructive sleep apnea.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Arens, R, McDonough, JM, Costarino, A, et al. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2001; 164:698. Official Journal of the American Thoracic Society. Copyright &copy;2001 American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20086=[""].join("\n");
var outline_f19_39_20086=null;
var title_f19_39_20087="Clinical features of hematogenous osteomyelitis in children";
var content_f19_39_20087=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features of hematogenous osteomyelitis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20087/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20087/contributors\">",
"     Paul Krogstad, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20087/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20087/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20087/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20087/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/39/20087/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis is an infection of bone that is usually bacterial in origin. Microorganisms can be introduced into bone in three ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hematogenous delivery",
"     </li>",
"     <li>",
"      Direct inoculation (usually traumatic, but also surgical)",
"     </li>",
"     <li>",
"      Local invasion from a contiguous infection (usually decubitus ulcer or periodontal disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children, acute osteomyelitis is primarily hematogenous in origin. Unique anatomic characteristics of the growing skeleton affect the site of infection, pathogenesis, and clinical features of hematogenously spread disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical features of hematogenous osteomyelitis in children will be reviewed here. The epidemiology, pathogenesis, microbiology, evaluation, diagnosis, and treatment of hematogenous osteomyelitis in children are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24730?source=see_link\">",
"     \"Treatment of hematogenous osteomyelitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several retrospective series have characterized the incidence of the principal clinical features of osteomyelitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fever (40 to 80 percent)",
"     </li>",
"     <li>",
"      Localized pain (56 to 95 percent)",
"     </li>",
"     <li>",
"      Decreased mobility (50 to 84 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Beyond the newborn period, only one bone usually is involved in acute hematogenous osteomyelitis, but polyostotic (multifocal) disease may be occurring more frequently (7.5 percent of cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/5\">",
"     5",
"    </a>",
"    ]. This may reflect the dramatic increase in disease caused by community-acquired methicillin-resistant Staphylococcus aureus.",
"   </p>",
"   <p>",
"    The clinical features of culture-negative osteomyelitis (20 to 50 percent of cases) differ from those in cases in which a pathogen is identified [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/3,4,6-8\">",
"     3,4,6-8",
"    </a>",
"    ]. This was best shown in a retrospective review that compared children with culture-negative and culture-positive osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/8\">",
"     8",
"    </a>",
"    ]. Culture-positive osteomyelitis was more frequently associated with:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A history of antecedent trauma",
"     </li>",
"     <li>",
"      Erythema, swelling, or frank cellulitis overlying the infected bone",
"     </li>",
"     <li>",
"      A shorter duration of symptoms",
"     </li>",
"     <li>",
"      A higher white blood cell count",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Duration of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis can be acute (hematogenous), subacute, or chronic, and the manifestations may vary with the duration of infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Acute hematogenous osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical acute osteomyelitis has a gradual onset over several days to one week. The initial symptoms of acute hematogenous osteomyelitis can be nonspecific in children of all ages, and commonly include malaise and low-grade fever. As a result, the child may not present for medical care until symptoms referable to bone develop. This was illustrated in a study of 102 children with hematogenous osteomyelitis diagnosed at a children's hospital in Australia: 44 percent had symptoms for three days or more, and 22 percent were symptomatic for more than one week [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once infection becomes established in bone, symptoms related to pain (such as decreased movement of the affected area) and local swelling develop. The evolution of this process is age related and reflects the developmental anatomy of bone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Subacute osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute osteomyelitis, which is associated with a longer duration of symptoms (weeks to months), is most often observed in adolescents who present with complaints of pain and tenderness in the long bones, such as the tibia and femur. The pain is less severe, there is minimal fever, and there are few constitutional symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Chronic osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection generally is considered chronic when signs and symptoms of bone inflammation have been present for at least two weeks and there is radiographic evidence of devitalized bone. Chronic osteomyelitis usually occurs after a surgical procedure or major trauma, but it also can develop after inadequate treatment of hematogenous osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic osteomyelitis is easily recognized when it occurs in a patient with a history of osteomyelitis who is experiencing a recurrence of pain, erythema, and swelling in association with a draining sinus [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/9\">",
"     9",
"    </a>",
"    ]. In some cases, however, the diagnosis of chronic osteomyelitis is made in a child who has had longstanding musculoskeletal complaints.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NEWBORNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis in the newborn is rare and usually occurs in infants with risk factors such as prematurity, skin infections, and complicated delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/10\">",
"     10",
"    </a>",
"    ]. Antecedent infections are present in one-half of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/11\">",
"     11",
"    </a>",
"    ]. They are usually nosocomial and include pneumonia, line-associated bacteremia, and infections of heel puncture sites, arterial cannulas, and cephalohematomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constitutional symptoms of osteomyelitis in the newborn are frequently mild. Many infants are afebrile and continue to feed well, although vomiting and irritability may be observed. In one report, for example, fever was noted in only 10 of 30 infants diagnosed with hematogenous osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/12\">",
"     12",
"    </a>",
"    ]. Four of the infants in this report had blood cultures positive for S. aureus with no focal signs of osteomyelitis.",
"   </p>",
"   <p>",
"    Common initial signs are decreased movement, swelling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    erythema of the affected area. The epiphysis and adjacent joint become involved in 60 to 70 percent of patients as the infection progresses. Soft tissue surrounding the infected bone may become swollen and discolored as purulence ruptures into the contiguous muscle bed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical features also may vary with the specific pathogen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      S. aureus, the most common cause of neonatal osteomyelitis, frequently is associated with systemic symptoms. In addition, multiple sites of infection are common with both methicillin-susceptible and methicillin-resistant isolates.",
"     </li>",
"     <li>",
"      Group B streptococcal infection usually affects a single bone without a clinically evident preceding infection. Affected patients also are usually older (two to four weeks).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Vertebral infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertebral osteomyelitis is rare in newborns and difficult to diagnose. Although some infants may be highly febrile and toxic-appearing, most have nonspecific symptoms and signs that are often overlooked, even in closely monitored settings such as neonatal intensive care units [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/13\">",
"     13",
"    </a>",
"    ]. The infant may eventually develop irritability when moved, or have signs of infection at another site.",
"   </p>",
"   <p>",
"    As a result of this often-unrecognized indolent presentation, a paraspinal abscess can be present at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Collapse of one or more vertebral bodies also may occur, resulting in kyphosis or paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     OLDER INFANTS AND TODDLERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with children of all ages, the initial symptoms of hematogenous osteomyelitis in older infants and toddlers are frequently nonspecific and mild. Unlike newborns, however, toddlers may complain of localized pain. There also may be a history of nonspecific trauma at the onset of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the illness progresses, the child may refuse to use the affected extremity. In an ambulating child, a limp is often a presenting complaint when the lower extremity or pelvis is involved [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/16\">",
"     16",
"    </a>",
"    ]. Focal pain and contiguous edema may develop.",
"   </p>",
"   <p>",
"    Children with pelvic osteomyelitis often have a gait abnormality and hip pain; fever is commonly absent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/17\">",
"     17",
"    </a>",
"    ]. Unlike those with septic arthritis, these patients allow passive range of motion of the hip. However, pain may be elicited by simultaneously putting the hip in flexion, abduction, and external rotation. In addition, careful palpation and rectal examination may reveal areas of point tenderness.",
"   </p>",
"   <p>",
"    In contrast to newborns, pus rarely spreads to the soft tissues because the cortex of the bone is thicker and the periosteum more dense. Consequently, pain is generally well localized, with point tenderness over the infected bone. In addition, pain is referred to this area when other parts of the bone are percussed. It may be challenging, however, to elicit these findings in a young child. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Vertebral infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertebral infections in older infants and toddlers usually involve the disc rather than the vertebral body. This may reflect the persistence in young children of vascular channels that supply the cartilaginous portion of the disc; in older children, these channels appear to undergo involution. Fever generally is absent or low-grade in children with discitis. High lesions (T8 to L1) can cause abdominal pain, ileus, and vomiting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H14#H14\">",
"     \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Vertebral osteomyelitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because symptoms and signs are frequently gradual in onset and subtle in character, the mean duration of symptoms prior to diagnosis can be variable and the diagnosis delayed. In a series of 36 children with discitis treated at a tertiary children's hospital, the mean duration of symptoms at the time of diagnosis was 22 days [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The young child with vertebral infection (discitis or vertebral osteomyelitis) may refuse to sit, walk, or may present with a progressive limp. By comparison, older children complain of back pain. Nonambulatory infants often become irritable and refuse to sit. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Vertebral infection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    On examination, there is percussion tenderness over the contiguous spine. In addition, hip pain and stiffness, with loss of lumbar lordosis, can be present. On occasion, compression of the spine produces pain at the infected disc.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CHILDREN AND ADOLESCENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In late childhood and adolescence, patients are more likely to complain of localized pain. An injury, rather than infection, may be suspected initially, particularly in the child without fever or constitutional symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;On physical examination, extremity function is less restricted compared with younger children because of relatively less swelling and a more anatomically confined infectious process. The point tenderness is therefore also more circumscribed. Children with pelvic osteomyelitis often have symptoms referable to the hip, such as a gait abnormality and hip pain. Unlike those with septic arthritis, these patients allow passive range of motion of the hip. However, as with younger children, pain may be elicited by simultaneously putting the hip in flexion, abduction, and external rotation. Point tenderness is also commonly detected on examination [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although many children in this age group lack systemic signs of infection, a severe staphylococcal sepsis syndrome has been described in some adolescents with osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. In addition, a subacute process, resulting in the formation of an intraosseous abscess known as a Brodie abscess (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87102 \" href=\"UTD.htm?35/54/36709\">",
"     image 1",
"    </a>",
"    ), occurs most often in adolescents. These patients present with complaints of long bone pain and tenderness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Vertebral infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with vertebral osteomyelitis usually are older than eight years of age and seek medical attention because of dull, constant back pain. They may appear toxic and markedly febrile after an indolent course with low-grade fever for two weeks' to several months' duration [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/18\">",
"     18",
"    </a>",
"    ]. Unlike younger children, who often come to medical attention with difficulty walking, older children complain of back pain.",
"   </p>",
"   <p>",
"    Discitis and vertebral osteomyelitis can be differentiated by age, duration of symptoms, and presence of fever at presentation. One retrospective series compared the clinical characteristics of 36 children diagnosed with discitis and 14 children diagnosed with vertebral osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/18\">",
"     18",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean age of the children with discitis was younger than those with vertebral osteomyelitis (2.8 years and 7.5 years, respectively).",
"     </li>",
"     <li>",
"      Of children with discitis, 85 percent of those &lt;3 years of age had a limp or refused to walk. Of those &ge;3 years of age, 67 percent complained of back pain. Fifty-seven percent of children with vertebral osteomyelitis complained of back pain.",
"     </li>",
"     <li>",
"      The mean duration of symptoms for patients with discitis was shorter than for those with vertebral osteomyelitis (22 and 33 days, respectively).",
"     </li>",
"     <li>",
"      Fewer of the children with discitis were febrile at initial presentation than with vertebral osteomyelitis (28 and 79 percent, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In cases of vertebral osteomyelitis, percussion of the spinal dorsal process frequently elicits exquisite tenderness. Usually, the paraspinous muscles around the involved vertebrae are in spasm. The patient often reports pain with flexion or extension of the spine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     OSTEOMYELITIS ASSOCIATED WITH CHRONIC ILLNESS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hemoglobinopathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;After pneumonia, hematogenous osteomyelitis is the most common serious bacterial infection in children with sickle cell disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/22\">",
"     22",
"    </a>",
"    ]. Patients at risk are those with hemoglobin SS, hemoglobin S-Thal, hemoglobin SO-Arab, and certain children with hemoglobin SC disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of hematogenous osteomyelitis are similar to those for other children, but may be difficult to distinguish from a vasoocclusive crisis. Multiple sites are often involved. Osteomyelitis in patients with sickle cell disease is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18506?source=see_link\">",
"     \"Bone and joint complications in sickle cell disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Chronic granulomatous disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic granulomatous disease (CGD) encompasses a heterogeneous group of disorders characterized by genetic defects in the ability of phagocytes to generate reactive oxygen intermediates from molecular oxygen. As a result, phagocytes fail to kill intracellular organisms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link\">",
"     \"Primary disorders of phagocytic function: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with CGD typically experience recurrent infections, including osteomyelitis, caused by bacterial and fungal pathogens. They frequently have minimal clinical signs and symptoms despite the presence of well-established, frequently destructive infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Chronic hemodialysis patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children undergoing chronic hemodialysis are at greater risk for hematogenous osteomyelitis because of repeated invasions of their vascular compartment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/25\">",
"     25",
"    </a>",
"    ]. Indwelling intravenous cannulas can be colonized with coagulase-negative staphylococci or S. aureus, and osteomyelitis may develop. The thoracic spine and ribs are the bones most commonly involved; other tubular and cuboidal bones that have been traumatized also can become infected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Human immunodeficiency virus infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although recurrent invasive bacterial infections often complicate human immunodeficiency virus (HIV) infection, there are few reports of osteomyelitis in these patients. Many of the existing reports involve patients with recent intravenous drug use, which probably acted as the principal predisposing factor. To date, there is no evidence that the presenting signs and symptoms or treatment needed for recovery from osteomyelitis are affected by co-infection with HIV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     VENOUS THROMBOSIS AND SEPTIC EMBOLI ASSOCIATED WITH OSTEOMYELITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous thrombosis and septic emboli may occur in older children and adolescents with osteomyelitis caused by Staphylococcus aureus, resulting in prolonged hospitalization (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58955 \" href=\"UTD.htm?21/3/21552\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/21,26-29\">",
"     21,26-29",
"    </a>",
"    ]. Reports have identified this association in infections involving both methicillin-susceptible and methicillin-resistant strains.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a case series from Houston, seven of nine patients with venous thrombosis were infected with community-associated methicillin-resistant S. aureus (CA-MRSA) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/21\">",
"       21",
"      </a>",
"      ]. In addition, all seven isolates carried the Panton-Valentine leukocidin genes, which are associated with virulence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=see_link&amp;anchor=H10#H10\">",
"       \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'CA-MRSA strains'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In another case series from Dallas, 10 of 35 patients with osteomyelitis of the proximal upper or lower extremity, pelvis, or spine developed deep venous thrombosis [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/28\">",
"       28",
"      </a>",
"      ]. Among these 10 patients, seven were infected with MRSA, two with methicillin-susceptible S. aureus, and one with Candida tropicalis; six had evidence of disseminated infection (to the lung, brain, or heart) compared with only 1 of 25 patients without venous thrombosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The reason for the association between venous thrombosis, septic embolus, and osteomyelitis is unknown. All of the patients from the Houston series, and 8 of 10 of those from the Dallas series, developed thrombosis at sites adjacent to the osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/21,28\">",
"     21,28",
"    </a>",
"    ]. In addition, four of nine patients from Houston and six of the seven patients from Dallas who were evaluated for thrombophilia had abnormal results, most of which resolved over time [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/21,28\">",
"     21,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Comparison of children from a single institution with osteomyelitis who did (n=11) and did not (n=201) develop thromboembolism suggests that thromboembolism is more common in children older than eight years who have MRSA osteomyelitis and who have CRP &gt;6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (60",
"    <span class=\"nowrap\">",
"     mg/L)",
"    </span>",
"    at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/29\">",
"     29",
"    </a>",
"    ]. Two of the nine patients with thromboembolism who were tested were heterozygous for coagulation abnormalities (one with a prothrombin 20210A mutation and one with a factor V Leiden mutation) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevations in peripheral white blood cell count (WBC) are variable and nonspecific, while elevations in the erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) are more consistently observed in children with hematogenous osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/4,30\">",
"     4,30",
"    </a>",
"    ]. This was illustrated in a review of 44 children with acute hematogenous osteomyelitis in whom serial tests were obtained during therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20087/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The white blood cell count was elevated in only 35 percent.",
"     </li>",
"     <li>",
"      The erythrocyte sedimentation rate (ESR) was initially elevated (&ge;20",
"      <span class=\"nowrap\">",
"       mm/h)",
"      </span>",
"      in 92 percent of patients (mean 45",
"      <span class=\"nowrap\">",
"       mm/h).",
"      </span>",
"     </li>",
"     <li>",
"      The serum C-reactive protein (CRP) concentration was elevated in 98 percent on admission.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Changes in the WBC, ESR, and CRP level toward normal values are frequently used as indicators of the response to therapy. This issue is discussed in detail elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24730?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of hematogenous osteomyelitis in children\", section on 'Monitoring tools'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial symptoms of hematogenous osteomyelitis can be nonspecific in children of all ages and are typically those associated with bacteremia, such as malaise and low-grade fever. Once infection becomes established in bone, symptoms related to pain, such as decreased movement of the affected area, and local swelling develop. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'General clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Some clinical features of osteomyelitis are age related:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In newborns, infection ruptures through the thin cortex of bone into contiguous muscle bed, resulting in soft-tissue swelling and erythema. The epiphysis and adjacent joint are involved in many patients. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Newborns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Older infants often initially have mild symptoms. As the illness progresses, focal pain and contiguous edema develop. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Older infants and toddlers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In late childhood and adolescence, patients are more likely to complain of localized pain. On physical examination, extremity function is less restricted compared with younger children. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Children and adolescents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vertebral infections can involve either the intervertebral disc or vertebral body. Children with discitis typically are younger than those with vertebral osteomyelitis and have a delayed presentation, without fever. Clinical features also vary with age:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vertebral osteomyelitis is rare in newborns and difficult to diagnose. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Vertebral infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Presenting complaints of vertebral osteomyelitis in older infants and toddlers include progressive limp and irritability with localized pain on physical examination. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Vertebral infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Older children and adolescents with vertebral osteomyelitis are more often toxic-appearing and highly febrile. Back pain and percussion tenderness over the involved spinal dorsal process are seen frequently. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Vertebral infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with associated medical conditions, such as hemoglobinopathies, chronic granulomatous disease, and those undergoing chronic hemodialysis can be at risk for osteomyelitis. Deep vein thrombosis and septic emboli have occurred in previously healthy patients with osteomyelitis. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Venous thrombosis and septic emboli associated with osteomyelitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    General laboratory findings are variable and nonspecific. Elevations in WBC are inconsistent; ESR and CRP are elevated in most patients. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Laboratory findings'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/1\">",
"      Goergens ED, McEvoy A, Watson M, Barrett IR. Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health 2005; 41:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/2\">",
"      Scott RJ, Christofersen MR, Robertson WW Jr, et al. Acute osteomyelitis in children: a review of 116 cases. J Pediatr Orthop 1990; 10:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/3\">",
"      Bonhoeffer J, Haeberle B, Schaad UB, Heininger U. Diagnosis of acute haematogenous osteomyelitis and septic arthritis: 20 years experience at the University Children's Hospital Basel. Swiss Med Wkly 2001; 131:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/4\">",
"      Karwowska A, Davies HD, Jadavji T. Epidemiology and outcome of osteomyelitis in the era of sequential intravenous-oral therapy. Pediatr Infect Dis J 1998; 17:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/5\">",
"      Gafur OA, Copley LA, Hollmig ST, et al. The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines. J Pediatr Orthop 2008; 28:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/6\">",
"      Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants and children. A review of 163 cases. Am J Dis Child 1975; 129:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/7\">",
"      Nelson JD. Acute osteomyelitis in children. Infect Dis Clin North Am 1990; 4:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/8\">",
"      Floyed RL, Steele RW. Culture-negative osteomyelitis. Pediatr Infect Dis J 2003; 22:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/9\">",
"      Ramos OM. Chronic osteomyelitis in children. Pediatr Infect Dis J 2002; 21:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/10\">",
"      Knudsen CJ, Hoffman EB. Neonatal osteomyelitis. J Bone Joint Surg Br 1990; 72:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/11\">",
"      Asmar BI. Osteomyelitis in the neonate. Infect Dis Clin North Am 1992; 6:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/12\">",
"      Wong M, Isaacs D, Howman-Giles R, Uren R. Clinical and diagnostic features of osteomyelitis occurring in the first three months of life. Pediatr Infect Dis J 1995; 14:1047.",
"     </a>",
"    </li>",
"    <li>",
"     Overturf, GA, Marcy, SM. Bacterial infections of the bones and joints. In Infectious diseased of the fetus and newborn infant, 5th ed, Remington, JS, Klein, JO (Eds), WB Saunders, Philadelphia 2001. p.1024.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/14\">",
"      Ein SH, Shandling B, Humphreys R, Krajbich I. Osteomyelitis of the cervical spine presenting as a neurenteric cyst. J Pediatr Surg 1988; 23:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/15\">",
"      Barton LL, Villar RG, Rice SA. Neonatal group B streptococcal vertebral osteomyelitis. Pediatrics 1996; 98:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/16\">",
"      Weber-Chrysochoou C, Corti N, Goetschel P, et al. Pelvic osteomyelitis: a diagnostic challenge in children. J Pediatr Surg 2007; 42:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/17\">",
"      Kumar J, Ramachandran M, Little D, Zenios M. Pelvic osteomyelitis in children. J Pediatr Orthop B 2010; 19:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/18\">",
"      Fernandez M, Carrol CL, Baker CJ. Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics 2000; 105:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/19\">",
"      Mustafa MM, S&aacute;ez-Llorens X, McCracken GH Jr, Nelson JD. Acute hematogenous pelvic osteomyelitis in infants and children. Pediatr Infect Dis J 1990; 9:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/20\">",
"      Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/21\">",
"      Gonzalez BE, Teruya J, Mahoney DH Jr, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006; 117:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/22\">",
"      Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971; 50:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/23\">",
"      Griesemer DA, Winkelstein JA, Luddy R. Pneumococcal meningitis in patients with a major sickle hemoglobinopathy. J Pediatr 1978; 92:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/24\">",
"      Specht EE. Hemoglobinopathic salmonella osteomyelitis. Orthopedic aspects. Clin Orthop Relat Res 1971; 79:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/25\">",
"      Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am 2001; 15:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/26\">",
"      Gorenstein A, Gross E, Houri S, et al. The pivotal role of deep vein thrombophlebitis in the development of acute disseminated staphylococcal disease in children. Pediatrics 2000; 106:E87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/27\">",
"      Walsh S, Phillips F. Deep vein thrombosis associated with pediatric musculoskeletal sepsis. J Pediatr Orthop 2002; 22:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/28\">",
"      Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr 2006; 149:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/29\">",
"      Hollmig ST, Copley LA, Browne RH, et al. Deep venous thrombosis associated with osteomyelitis in children. J Bone Joint Surg Am 2007; 89:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20087/abstract/30\">",
"      Unkila-Kallio L, Kallio MJ, Eskola J, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics 1994; 93:59.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6064 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-965172F715-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20087=[""].join("\n");
var outline_f19_39_20087=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Duration of infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Acute hematogenous osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Subacute osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Chronic osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NEWBORNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Vertebral infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      OLDER INFANTS AND TODDLERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Vertebral infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CHILDREN AND ADOLESCENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Vertebral infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      OSTEOMYELITIS ASSOCIATED WITH CHRONIC ILLNESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hemoglobinopathies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Chronic granulomatous disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Chronic hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Human immunodeficiency virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      VENOUS THROMBOSIS AND SEPTIC EMBOLI ASSOCIATED WITH OSTEOMYELITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6064\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6064|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/54/36709\" title=\"diagnostic image 1\">",
"      Brodie abscess radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/3/21552\" title=\"diagnostic image 2\">",
"      Septic emboli MRSA osteo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18506?source=related_link\">",
"      Bone and joint complications in sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=related_link\">",
"      Evaluation and diagnosis of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24730?source=related_link\">",
"      Treatment of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20088="When to use rabies prophylaxis";
var content_f19_39_20088=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   When to use rabies prophylaxis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20088/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20088/contributors\">",
"     Alfred DeMaria, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20088/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20088/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20088/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20088/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/39/20088/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies is a fatal viral disease primarily acquired from the bite of a rabid animal, with only six cases of documented human survival prior to 2004. However, since that time there have been three documented survivors who had not received any pre-exposure",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infection can be prevented with proper postexposure prophylaxis, as first pioneered by Louis Pasteur in 1885. While up to 50,000 people worldwide die of rabies every year, only 69 cases of human rabies were diagnosed in the United States from 1980 through 2010, an average of approximately two per year [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. This low rate of human cases in the United States reflects the success of domestic animal control and vaccination programs. The predominant reservoir of rabies in the United States is now wildlife, with most cases occurring in raccoons, skunks, foxes and bats.",
"   </p>",
"   <p>",
"    The recommendations of the Advisory Committee on Immunization Practices (ACIP) for rabies postexposure prophylaxis are reviewed here [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/4\">",
"     4",
"    </a>",
"    ]. These guidelines can be accessed through the Centers for Disease Control and Prevention's website at",
"    <a class=\"external\" href=\"file://www.cdc.gov/rabies/\">",
"     file://www.cdc.gov/rabies/",
"    </a>",
"    and should be checked periodically for updates. The use of rabies biologics (vaccine and immunoglobulin) and the clinical features and treatment of human rabies are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29624?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors need to be considered in deciding whether to administer postexposure rabies prophylaxis. These include [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The epidemiology of animal rabies in the region",
"     </li>",
"     <li>",
"      The type of exposure",
"     </li>",
"     <li>",
"      Whether the exposure was provoked or unprovoked",
"     </li>",
"     <li>",
"      The species and vaccination status of the animal",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The decision whether to initiate rabies postexposure prophylaxis also depends on whether the exposing animal is a dog, cat, or ferret, and can be observed or tested for rabies.",
"   </p>",
"   <p>",
"    Some circumstances of possible rabies exposure and clinical issues can be complex; physicians should seek the help of local public health authorities for further advice regarding the need for postexposure prophylaxis (",
"    <a class=\"graphic graphic_algorithm graphicRef71322 \" href=\"UTD.htm?6/36/6720\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANIMAL RABIES EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The guidelines for rabies postexposure prophylaxis differ depending upon the species of animal involved in the exposure and the country in which the exposure occurs (",
"    <a class=\"graphic graphic_table graphicRef67426 \" href=\"UTD.htm?33/55/34683\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Information about testing and observing animals with suspected rabies is found below. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Animal observation and testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Domestic animal rabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of rabies cases among domestic animals, such as dogs or cats, has declined markedly in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, the probability of human exposure to a rabid domestic animal in the United States is low, but varies by region. In the continental United States, rabies among dogs is most often reported along the United States-Mexico border. However, sporadic cases do occur outside of this area, particularly in areas with enzootic wildlife rabies. Domestic animals incubating rabies, including dogs, may also be imported from regions of the world where domestic animal rabies is still enzootic.",
"   </p>",
"   <p>",
"    More cats than dogs are currently reported rabid in the United States. This is related to fewer cat vaccination laws, which results in a smaller percentage of cats vaccinated against rabies compared to dogs. Cats are also more free roaming than dogs and more likely to encounter rabid wildlife.",
"   </p>",
"   <p>",
"    In most countries outside of the United States, dogs remain the most common source of rabies among humans [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/6\">",
"     6",
"    </a>",
"    ]. Among 45 cases of human rabies diagnosed in the United States between 1995 and 2011, 10 were attributed to exposure to dogs outside the United States and one was mongoose rabies strain attributed to a dog bite in Puerto Rico [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/3\">",
"     3",
"    </a>",
"    ]. The incubation period for such imported cases can be as long as six years [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, international travelers to areas where dog rabies is enzootic have risk for exposure to rabies. Biting dogs outside of the United States, in countries where dog rabies is enzootic, should be always considered rabid if not available for testing or observation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Bats",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bat rabies is found in all 49 continental United States and in many other countries around the world. Between 1995 and 2011, of 32 human rabies cases acquired within the continental US, 30 were due to strains of rabies virus associated with bats.",
"   </p>",
"   <p>",
"    If a potential human exposure to a bat has occurred, the bat should be safely collected and submitted for testing, if possible. Unless the bat is available for testing and is negative, postexposure prophylaxis is recommended for all persons with bites, scratches, or mucous membrane exposures to bats.",
"   </p>",
"   <p>",
"    These recommendations do not account for the existing epidemiologic data suggesting possible transmission from unrecognized bat bites. Please (see",
"    <a class=\"local\" href=\"#H10\">",
"     'Bat exposures'",
"    </a>",
"    below) regarding other instances when prophylaxis might be considered.",
"   </p>",
"   <p>",
"    Where possible, human and domestic animal contact with bats should be avoided. Bats should never be kept as pets and should not be picked up or handled by anyone except trained and vaccinated persons.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Wild terrestrial mammals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Terrestrial carnivores are the most likely wild animals to be infected with rabies; in the United States raccoons, skunks, foxes and coyotes are the most common infected species (",
"    <a class=\"graphic graphic_figure graphicRef77282 \" href=\"UTD.htm?25/28/26051\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/8\">",
"     8",
"    </a>",
"    ]. Such animals should be regarded as rabid until proven otherwise and postexposure prophylaxis should be initiated in response to any bite or other significant exposure. If the animal can be safely captured, it should be euthanized and tested as soon as possible. If the exposure is of lower risk (non-bite, minimal bite wound to lower extremity, etc.) and the animal is tested promptly, postexposure prophylaxis can await the results of testing. Otherwise, the vaccination series may be discontinued if the animal tests negative for rabies.",
"   </p>",
"   <p>",
"    Rabies has been reported in large rodents (woodchucks and beavers) in areas of the United States where raccoon rabies is prevalent. Small rodents, such as squirrels, chipmunks, rats, hamsters, gerbils, guinea pigs, mice, and lagomorphs (rabbits and hares) are almost never identified as infected with rabies virus; there has",
"    <strong>",
"     never",
"    </strong>",
"    been a case of transmission to a human from one of these animals. If the animal is not available for testing, postexposure prophylaxis for bites involving any of these animals should be considered individually in consultation with the public health authorities (",
"    <a class=\"graphic graphic_table graphicRef67426 \" href=\"UTD.htm?33/55/34683\">",
"     table 1",
"    </a>",
"    ). However, rabies has been identified in lagomorphs and large rodents caged outdoors. These animals are at risk for exposure to rabid animals, but caging may protect them from severe injury or death from encounters with infected wildlife [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/9\">",
"     9",
"    </a>",
"    ]. This should be considered in evaluating the risk from lagomorph and rodent exposures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Livestock",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cases of rabies in livestock infected by wild animals have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/8\">",
"     8",
"    </a>",
"    ]. Livestock exposures to rabid and potentially rabid wild animals should be evaluated in consultation with agricultural agency officials. Cases of bites or non-bite exposures from livestock should be managed individually in consultation with local public health authorities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TYPES OF EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all cases of rabies are transmitted from rabid animals through a bite. In rare cases, rabies results from a non-bite exposure or transplantation of cornea, organ, or tissue from a human donor with unrecognized rabies.",
"   </p>",
"   <p>",
"    No transmission of rabies has been documented from rabies-infected patients to healthcare providers, or to household contacts, or by fomites or environmental surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/4,10\">",
"     4,10",
"    </a>",
"    ]. The rabies virus is inactivated quickly by drying, light exposure, and other environmental factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Bites",
"    </span>",
"    &nbsp;&mdash;&nbsp;All bites from animals that can be infected with rabies virus carry a risk of rabies transmission. The risk of acquisition increases with multiple bites, and with bites in closer proximity to the central nervous system (CNS) (",
"    <a class=\"graphic graphic_picture graphicRef50558 \" href=\"UTD.htm?24/9/24735\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/11\">",
"     11",
"    </a>",
"    ]. One study in Thailand demonstrated that the risk of dying of rabies, among individuals who did not receive postexposure prophylaxis, was highest in those who were severely bitten around the face, neck, and arms, compared with those who were bitten about the feet [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/12\">",
"     12",
"    </a>",
"    ]. Children, presumably because of their size (ie, their entire body is closer to the CNS), are more at risk as well. Bites by certain animals, particularly bats, may be too small to be routinely detected or may occur at night during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In developing countries, dogs account for 90 percent or more of reported cases in humans. Canine rabies was responsible for most human deaths in the United States prior to the 1950s, and was largely eliminated as a source by the 1940s. In the late 1970s, wild animals emerged as the source of the now rarer cases of human disease in the United States. During 2008, rabies animal surveillance in the United States identified the four major animal reservoirs as raccoons, bats, skunks, and foxes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/14\">",
"     14",
"    </a>",
"    ]. Since the 1980s, bat variant rabies viruses have emerged as the dominant source associated with indigenously acquired human rabies in the United States, and this continues to be the case [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Bat exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common rabies virus variants identified in infected humans in the United States are bat-related; therefore, any bat exposure needs thorough evaluation. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Animal rabies epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The risk for rabies resulting from an encounter with a bat is often difficult to assess because of the sometimes imperceptible bite inflicted by this mammal (",
"    <a class=\"graphic graphic_picture graphicRef50558 \" href=\"UTD.htm?24/9/24735\">",
"     picture 1",
"    </a>",
"    ). From 1990 to 2007, a total of 34 naturally acquired bat-associated human cases of rabies were reported. In 15 cases, physical contact was reported but no bite was documented, and in 11 cases no known bat encounter was reported at all [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/4\">",
"     4",
"    </a>",
"    ]. However, it should be noted that by the time rabies is diagnosed, getting an accurate history is usually precluded.",
"   </p>",
"   <p>",
"    The ACIP makes the following recommendations regarding bats:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postexposure prophylaxis should be considered when direct contact between a human and a bat has occurred (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Animal rabies epidemiology'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Postexposure prophylaxis is not necessary if the person was aware of the bat at all times while in an enclosed space and is certain that there was no bite, scratch, or mucous membrane exposure.",
"     </li>",
"     <li>",
"      If the bat is captured and can be tested for rabies, postexposure prophylaxis in persons without direct exposure can await the results of prompt testing. If uncertainty about the need for prophylaxis still exists, the local public health authority should be consulted.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ACIP also recommends that postexposure prophylaxis should be considered for an individual who has been in a room with a bat and who may be unable to rule out any physical contact. Such individuals might include: 1) a sleeping person who awakens to find a bat in the room; 2) an unattended child; 3) a mentally disabled person; or 4) an intoxicated person.",
"   </p>",
"   <p>",
"    However, the scientific basis and practical implications of these recommendations have been evaluated by estimating bedroom exposure to bats in a population survey of 14,453 households; the incidence of rabies was based on reported cases in the United States and Canada over a 17-year period [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/15\">",
"     15",
"    </a>",
"    ]. The number of individuals who would need to be treated to prevent a single case of bat rabies related to bedroom exposure without recognized contact ranged from 314,000 to 2.7 million persons, at a cost of 228 million to 2 billion dollars. The authors suggested that recommendations regarding post-exposure prophylaxis in non-bite bat exposures should be reconsidered. In fact, in Canada, the recommendation has been changed on the basis of this study to prophylaxis only for direct contact and if a bite, scratch, or saliva exposure cannot be ruled out [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Household members who were not in a room with the bat do not require postexposure prophylaxis. A clustering of human cases associated with bat exposures has never been reported (eg, within the same household or among campers at an outside camp).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Non-bite animal exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cases of rabies from non-bite exposures are extremely rare. Probable aerosol exposure to rabies virus in laboratories resulted in two cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Two other cases were attributed to possible aerosol exposures in caves containing millions of free-tailed bats (Tadarida brasiliensis) in the southwest United States [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/20\">",
"     20",
"    </a>",
"    ]. However, it is difficult to rule out inapparent bites as the route of transmission given the conditions in these caves.",
"   </p>",
"   <p>",
"    Two general conditions must be met for a non-bite exposure leading to a theoretical risk for rabies: the exposure is to the person's mucous membranes or open wounds, and the animal",
"    <span class=\"nowrap\">",
"     fluid/tissue",
"    </span>",
"    making contact is potentially infectious (such as saliva or neural tissue). Thus, exposure of normal, keratinized skin to any tissue does not constitute a rabies exposure. In addition, contact with blood, urine, or feces (guano) of a rabid animal does not constitute an exposure.",
"   </p>",
"   <p>",
"    Because the rabies virus is inactivated by desiccation and ultraviolet irradiation, a dry surface or object can be considered noninfectious.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Human-to-human transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human-to-human transmission of rabies can theoretically result from bite and non-bite exposures, but reports are very rare and poorly documented. However, human to human transmission arising from transplantation (corneas, organs, tissues) is well documented (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Risk for health care workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine delivery of health care to a patient with rabies is only considered to constitute a rabies exposure if mucous membranes or nonintact skin come in contact with potentially infectious body fluids or tissues (such as saliva, CSF, and neural tissue). Standard infection control precautions would minimize the risk of any such exposure and should be routinely employed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. For example, staff should wear gowns, masks, and gloves, and",
"    <span class=\"nowrap\">",
"     eye/face",
"    </span>",
"    protection when there is risk of aerosols and splashes, particularly with respiratory secretions, especially during intubation and suctioning [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Transplant recipients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eight recipients of transplanted corneas have died of rabies [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/24-29\">",
"     24-29",
"    </a>",
"    ]. These cases occurred in Thailand (two cases), India (two cases), Iran (two cases), France (one case) and the United States (one case). In all of these cases, the donor was later found to have died of an illness that was either proved to be, or was, compatible with rabies. Guidelines for corneal transplantation have since been implemented which reject corneas from those dying of unexplained encephalitis.",
"   </p>",
"   <p>",
"    In 2004, rabies transmission was documented from a solid",
"    <span class=\"nowrap\">",
"     organ/tissue",
"    </span>",
"    donor to transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/30\">",
"     30",
"    </a>",
"    ]. The organ donor died from a subarachnoid hemorrhage following an illness characterized by severe mental status changes and a low-grade fever. The death was attributed to noninfectious causes. Organs and tissues were recovered and transplanted. Three recipients of organs and one recipient of vascular tissue subsequently died of laboratory-confirmed rabies. A follow-up public health investigation determined that the donor had reported being bitten by a bat, and bat strain rabies was identified [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/31\">",
"     31",
"    </a>",
"    ]. Later in 2004, a similar cluster of rabies in transplant recipients occurred in Germany [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Bite and non-bite exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bite and non-bite exposures from humans with rabies could theoretically transmit the virus. Two cases of purported human-to-human transmission in Ethiopia have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/33\">",
"     33",
"    </a>",
"    ]. In one case, the reported route of exposure was a bite, in the other, a kiss. No such cases, with laboratory confirmation of rabies, exist. Given the conditions under which most of the world's rabies patients are cared for, the lack of more reported cases, confirmed or otherwise, suggests human-to-human transmission is extremely rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ANIMAL OBSERVATION AND TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from rabies pathogenesis studies in dogs, cats, and ferrets indicate that these animals uniformly begin to sicken and die within 10 days (usually five to seven days) of spread of rabies virus from the CNS to the salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/34\">",
"     34",
"    </a>",
"    ]. For this reason, a healthy domestic dog, cat, or ferret that bites a person should be confined and observed for 10 days. Animals that exhibit any sign of illness should be evaluated by a veterinarian and reported to the local health department. If the animal does develop any signs of illness, it should be euthanized and its head shipped under refrigeration to a laboratory certified to perform rabies testing (most often a public health laboratory). If the animal remains healthy for the full 10 days, then it did not have rabies virus in its saliva at the time of exposure.",
"   </p>",
"   <p>",
"    Postexposure prophylaxis should be given immediately if an exposing animal is rabid or suspected to be rabid. If the animal is available for observation, immediate prophylaxis is indicated when the animal develops clinical signs of illness. In addition, prophylaxis should be started if the person's significant exposure is to the head or neck, since incubation periods as short as four days have been reported in bites this close to the central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/11\">",
"     11",
"    </a>",
"    ]. If the animal remains well for 10 days, the regimen can be discontinued at that time. If the animal is tested for rabies and is found negative, prophylaxis can be discontinued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     VACCINATION STATUS OF DOMESTIC ANIMALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A dog, cat, or ferret in the United States with recommended vaccinations that are up-to-date is unlikely to become infected with rabies. However, cases of rabies have been reported in animals thought to be vaccinated, and therefore, guidelines for observation of such animals after an exposure incident exist and should be observed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PROVOKED VERSUS UNPROVOKED EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unprovoked attacks are more likely by rabid than non-rabid animals. Bites that occur when a person is trying to handle or feed an animal should be considered provoked attacks.",
"   </p>",
"   <p>",
"    Other factors to consider:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Any behavioral changes in the animal",
"     </li>",
"     <li>",
"      Vaccination status",
"     </li>",
"     <li>",
"      Any history of bites or wounds on the animal to suggest it has had a possible rabies exposure",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     HIGH-RISK GROUPS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preexposure prophylaxis should be targeted to persons at high risk for potential exposure to a rabid animal due to occupation or travel to an area with uncontrolled enzootic rabies in animals. This includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Veterinarians, veterinary students, and veterinary technicians",
"     </li>",
"     <li>",
"      Laboratory workers working with rabies virus or material and specimens that might contain infectious rabies virus",
"     </li>",
"     <li>",
"      Other persons whose vocation or avocation bring them in contact with animal species at risk for rabies (eg, cavers)",
"     </li>",
"     <li>",
"      International travelers, who are likely to come into contact with animals during stays in countries where dog rabies is enzootic and rapid access to medical care, particularly biologics, may not be readily available",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, shortages of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    due to supply issues among licensed manufacturers in the United States have occurred and most likely will recur. In these cases, vaccine for preexposure prophylaxis may be restricted or rationed to maintain supplies for postexposure prophylaxis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .) If, however, preexposure vaccination cannot be safely delayed or postexposure prophylaxis is required, and vaccine is not readily available, the local public health authority should be consulted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Rationale for preexposure prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preexposure prophylaxis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Provides protection for inapparent exposures to rabies virus, such as in laboratory workers",
"     </li>",
"     <li>",
"      Eliminates the need for rabies immune globulin (RIG) for postexposure prophylaxis; this is particularly important in areas where RIG may be unavailable or unsafe",
"     </li>",
"     <li>",
"      Affords some protection when postexposure prophylaxis may be delayed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Booster doses of vaccine are recommended when there is ongoing high-risk exposure. Vaccine schedules and recommendations for serologic testing are found elsewhere (",
"    <a class=\"graphic graphic_table graphicRef61388 \" href=\"UTD.htm?16/6/16492\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     COUNSELING TRAVELERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The discussion of preexposure prophylaxis is only one part of proper counseling for travelers to rabies-enzootic regions of the world (including most of Asia, Africa, Mexico, and Latin America) who may be visiting areas (rural, remote, non-touristic) where the danger of exposure may be higher and postexposure care may be difficult to access. They should always be advised about avoiding exposure to stray animals and proper care of wounds. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link&amp;anchor=H5#H5\">",
"     \"Rabies immune globulin and vaccine\", section on 'Wound care'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children are more likely to inadvertently provoke animals, are more likely to be injured because of their small stature, and are less likely to report exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/20\">",
"     20",
"    </a>",
"    ]. Thus, children should be closely supervised when traveling.",
"   </p>",
"   <p>",
"    Travelers in whom rabies preexposure prophylaxis should be encouraged include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persons who will be working with or around potentially rabid animals because of their vocation or avocation",
"     </li>",
"     <li>",
"      Children who will be living in rabies-endemic areas",
"     </li>",
"     <li>",
"      Persons who will be in areas where dog rabies is common, and who cannot be in a location where safe and effective biologics are reliably available within three days after exposure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The CDC maintains up-to-date information on rabies risks by region and country on its travel web site at:",
"    <a class=\"external\" href=\"file://wwwn.cdc.gov/travel/\">",
"     file://wwwn.cdc.gov/travel/",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Travelers who do not need or who do not receive preexposure prophylaxis should be counseled on how to access appropriate rabies biologics in the regions where they will be traveling in the event of an exposure. In all cases, these individuals should always receive both vaccine and RIG for postexposure prophylaxis, as is recommended in the United States. The American consulates abroad can often provide information on accessing these products.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Postexposure prophylaxis in resource-limited settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Travel medicine advisors should be aware that postexposure prophylaxis measures, undertaken in resource-limited countries within Asia or Africa, may differ from the ACIP guidelines, which are followed within the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/4\">",
"     4",
"    </a>",
"    ]. Because of a combination of limited resources and a high incidence of canine rabies exposure, many less-developed countries have adopted the World Health Organization (WHO) recommendations, which classify rabies exposure into three categories [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/23,36\">",
"     23,36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Category 1: Touching or feeding of animals, licks of animal on intact skin.",
"      <br/>",
"      <br/>",
"      Post-exposure prophylaxis is not recommended for category 1 exposures.",
"     </li>",
"     <li>",
"      Category 2: Nibbling of uncovered skin by animal with resultant minor scratches or abrasions (without bleeding).",
"      <br/>",
"      <br/>",
"      Post-exposure prophylaxis for category 2 exposures includes wound disinfection and administration of vaccine only. In contrast, the ACIP guidelines recommend both vaccine and RIG for this type of exposure. Thus, a traveler who returns to the United States with a history of having a scratch from a suspected rabid dog should also receive RIG, according to the ACIP guidelines. RIG should be administered no later than seven days after the start of an immunization series to avoid any suppression of the immune response to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"       rabies vaccine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Category 3: Single or multiple transdermal bites or scratches, licks on broken skin, contamination of mucous membrane with saliva, exposures to bats.",
"      <br/>",
"      <br/>",
"      Recommended postexposure treatment for category 3 exposure includes adequate wound care and RIG plus vaccine [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/23\">",
"       23",
"      </a>",
"      ], as recommended by the ACIP.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Travel advisors in the United States need to be aware that both biologic products and the route of vaccine administration in resource-limited settings may differ from that used in the US. Also, the WHO guidelines in 2010 have removed the rarely used eight-site regimen to simplify the use of intradermal postexposure prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/23,36,38,39\">",
"     23,36,38,39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a traveler returns home before completing a regimen in a resource-limited setting, it is not known whether completion of the immunization series with intramuscularly-administered",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    is effective or whether the entire series should be given de novo. In patients who have already completed most of the series abroad, we suggest completion of the immunization series with intramuscularly-administered rabies vaccine and documentation of a protective rapid fluorescent focus inhibition test (RFFIT) antibody titer. In patients who have received only a few doses abroad, we recommend a full series of vaccine licensed in the United States if there is any question about the vaccine product, administration route, or completeness of the regimen they have received.",
"   </p>",
"   <p>",
"    It may be prudent to tell travelers before their trip to request use of the intramuscular regimen if post-exposure prophylaxis is required while abroad. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The availability of vaccine is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25404486\">",
"    <span class=\"h1\">",
"     DELAYS IN PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies postexposure prophylaxis should begin as soon as possible after the exposure. Furthermore, since long latency periods between exposure and onset of disease have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/7\">",
"     7",
"    </a>",
"    ], postexposure prophylaxis should be given following a rabies exposure, regardless of the length of the delay. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     COST OF POSTEXPOSURE PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;While postexposure prophylaxis can prevent deaths in patients exposed to rabies domestically or while traveling abroad, the treatment regimen is expensive, costing over $1500 per person for biologics alone. It is estimated that approximately 40,000 people in the United States receive rabies postexposure prophylaxis annually [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Incidents involving large-scale exposure can generate high-level anxiety, which can lead to unnecessary rabies prophylaxis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A CDC report described a school incident where a parent showed a dead bat to multiple students, some of whom touched the carcass [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/41\">",
"       41",
"      </a>",
"      ]. The bat was later tested for rabies virus and was confirmed to be positive. The CDC assisted in public health recommendations for post-exposure prophylaxis after interviewing 107 students with potential exposures, but only recommended prophylaxis for one person who reported putting her finger in the mouth of the bat. However, 68 percent of the remaining persons still requested rabies prophylaxis for a total cost of $75,000.",
"     </li>",
"     <li>",
"      One prospective study of university-affiliated, urban emergency departments suggested that postexposure prophylaxis was given inappropriately in approximately 40 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20088/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2393351\">",
"    <span class=\"h1\">",
"     HOW SHOULD PROPHYLAXIS BE GIVEN?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rabies prophylaxis involves both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/55/16246?source=see_link\">",
"     rabies vaccine",
"    </a>",
"    and rabies immunoprophylaxis. Advice regarding route of administration and dosing is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=see_link\">",
"     \"Rabies immune globulin and vaccine\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/23/2418?source=see_link\">",
"       \"Patient information: Rabies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/15/22770?source=see_link\">",
"       \"Patient information: Animal bites (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rabies is an invariably fatal viral disease that can be prevented with proper wound care and postexposure prophylaxis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The decision to initiate rabies postexposure prophylaxis depends on many factors, including the type of exposure and whether the animal can be observed or tested for rabies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The guidelines for rabies postexposure prophylaxis differ depending upon the species of animal involved and the country in which the exposure occurred. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Animal rabies epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Almost all cases of rabies are transmitted from rabid animals through a bite. However, bat bites may be imperceptible. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Types of exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No transmission of rabies has been documented from rabies-infected patients to healthcare providers or household contacts or by fomites or environmental surfaces. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Types of exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bat rabies has been identified in the majority of human rabies cases occurring in the United States. Persons with direct contact with a bat should be offered rabies post-exposure prophylaxis as suggested by the ACIP. However, postexposure prophylaxis is not necessary if the person was aware of the bat at all times and is certain that there was no bite, scratch, or mucous membrane exposure. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Types of exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the bat is captured and can be tested for rabies, postexposure prophylaxis in persons without direct exposure can await the results of prompt testing. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Types of exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unprovoked attacks are more likely by animals that have rabies than animals without rabies. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Provoked versus unprovoked exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preexposure prophylaxis should be targeted to persons in high-risk groups, including veterinarians, laboratory workers and international travelers. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'High-risk groups'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most countries outside of the United States, dogs remain the most common source of rabies among humans. Travelers to rabies-enzootic areas should also be advised about avoiding exposure to stray animals and proper care of wounds. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Counseling travelers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traveler medicine advisors should be aware that post-exposure prophylaxis vaccines and immune globulins, as well as schedules received abroad may differ from regimens offered in the United States; thus additional prophylaxis may be necessary to abide by the ACIP guidelines. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Counseling travelers'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29630012\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editors of UpToDate, Inc. would like to acknowledge Wichai Techasathit, MD, MPH, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/1\">",
"      Centers for Disease Control and Prevention (CDC). Recovery of a patient from clinical rabies--California, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/2\">",
"      Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998; 128:922.",
"     </a>",
"    </li>",
"    <li>",
"     CDC. Human Rabies. file://www.cdc.gov/rabies/location/usa/surveillance/human_rabies.html (Accessed on August 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/4\">",
"      Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/5\">",
"      Rupprecht CE, Gibbons RV. Clinical practice. Prophylaxis against rabies. N Engl J Med 2004; 351:2626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/6\">",
"      Zinsstag J, Schelling E, Roth F, et al. Human benefits of animal interventions for zoonosis control. Emerg Infect Dis 2007; 13:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/7\">",
"      Smith JS, Fishbein DB, Rupprecht CE, Clark K. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 1991; 324:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/8\">",
"      Krebs JW, Smith JS, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1998. J Am Vet Med Assoc 1999; 215:1786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/9\">",
"      Eidson M, Matthews SD, Willsey AL, et al. Rabies virus infection in a pet guinea pig and seven pet rabbits. J Am Vet Med Assoc 2005; 227:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/10\">",
"      Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987; 9:511.",
"     </a>",
"    </li>",
"    <li>",
"     Fishbein DB. Rabies in humans. In: The natural history of rabies, Second Edition, Baer GM (Ed), CRC Press, Boca Raton, Florida 1991. p.519.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/12\">",
"      Sitthi-Amorn C, Jiratanavattana V, Keoyoo J, Sonpunya N. The diagnostic properties of laboratory tests for rabies. Int J Epidemiol 1987; 16:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/13\">",
"      Feder HM Jr, Nelson R, Reiher HW. Bat bite? Lancet 1997; 350:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/14\">",
"      Blanton JD, Robertson K, Palmer D, Rupprecht CE. Rabies surveillance in the United States during 2008. J Am Vet Med Assoc 2009; 235:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/15\">",
"      De Serres G, Skowronski DM, Mimault P, et al. Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxis. Clin Infect Dis 2009; 48:1493.",
"     </a>",
"    </li>",
"    <li>",
"     National Advisory Committee on Immunization (NACI). Recommendations Regarding the Management of Bat Exposures to Prevent Human Rabies. file://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09pdf/acs-dcc-07.pdf (Accessed on March 01, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/17\">",
"      Winkler WG, Fashinell TR, Leffingwell L, et al. Airborne rabies transmission in a laboratory worker. JAMA 1973; 226:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/18\">",
"      CDC. Rabies in a laboratory worker--New York. MMWR Morb Mortal Wkly Rep1977; 26:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/19\">",
"      Winkler WG, Baker EF Jr, Hopkins CC. An outbreak of non-bite transmitted rabies in a laboratory animal colony. Am J Epidemiol 1972; 95:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/20\">",
"      Afshar A. A review of non-bite transmission of rabies virus infection. Br Vet J 1979; 135:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/21\">",
"      Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control 2007; 35:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/22\">",
"      Mattner F, Henke-Gendo C, Martens A, et al. Risk of rabies infection and adverse effects of postexposure prophylaxis in healthcare workers and other patient contacts exposed to a rabies virus-infected lung transplant recipient. Infect Control Hosp Epidemiol 2007; 28:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/23\">",
"      WHO Expert Consultation on rabies. World Health Organ Tech Rep Ser 2005; 931:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/24\">",
"      Centers for Disease Control (CDC). Human-to-human transmission of rabies via corneal transplant--Thailand. MMWR Morb Mortal Wkly Rep 1981; 30:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/25\">",
"      Gode GR, Bhide NK. Two rabies deaths after corneal grafts from one donor. Lancet 1988; 2:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/26\">",
"      CDC. Human to human transmission of rabies via a corneal transplant--France. MMWR Morb Mortal Wkly Rep1980; 29:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/27\">",
"      Houff SA, Burton RC, Wilson RW, et al. Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979; 300:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/28\">",
"      WHO. Two rabies cases following corneal transplantation. Weekly Epidemiol Rec 1994; 69:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/29\">",
"      Javadi MA, Fayaz A, Mirdehghan SA, Ainollahi B. Transmission of rabies by corneal graft. Cornea 1996; 15:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/30\">",
"      Centers for Disease Control and Prevention (CDC). Investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/31\">",
"      Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/32\">",
"      Hellenbrand W, Meyer C, Rasch G, et al. Cases of rabies in Germany following organ transplantation. Euro Surveill 2005; 10:E050224.6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/33\">",
"      Fekadu M, Endeshaw T, Alemu W, et al. Possible human-to-human transmission of rabies in Ethiopia. Ethiop Med J 1996; 34:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/34\">",
"      Niezgoda M, Briggs DJ, Shaddock J, et al. Pathogenesis of experimentally induced rabies in domestic ferrets. Am J Vet Res 1997; 58:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/35\">",
"      National Association of State Public Health Veterinarians, Inc. Compendium of animal rabies prevention and control, 2011. MMWR Recomm Rep 2011; 60:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/36\">",
"      WHO Publication. Rabies vaccines: WHO position paper--recommendations. Vaccine 2010; 28:7140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/37\">",
"      Khawplod P, Wilde H, Chomchey P, et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine 1996; 14:389.",
"     </a>",
"    </li>",
"    <li>",
"     WHO. Recommendations on rabies postexposure treatment and the correct technique of intradermal immunization against rabies. Document EMC.ZOO 96.6. WHO, Geneva 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/39\">",
"      Wilde H, Khawplod P, Hemachudha T, Sitprija V. Postexposure treatment of rabies infection: can it be done without immunoglobulin? Clin Infect Dis 2002; 34:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/40\">",
"      Krebs JW, Smith JS, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1997. J Am Vet Med Assoc 1998; 213:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/41\">",
"      Centers for Disease Control and Prevention (CDC). Human exposures to a rabid bat - Montana, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20088/abstract/42\">",
"      Moran GJ, Talan DA, Mower W, et al. Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. Emergency ID Net Study Group. JAMA 2000; 284:1001.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8328 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-1FFB8D27E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20088=[""].join("\n");
var outline_f19_39_20088=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANIMAL RABIES EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Domestic animal rabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Bats",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Wild terrestrial mammals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Livestock",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TYPES OF EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Bites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Bat exposures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Non-bite animal exposures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Human-to-human transmission",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Risk for health care workers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Bite and non-bite exposures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ANIMAL OBSERVATION AND TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      VACCINATION STATUS OF DOMESTIC ANIMALS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PROVOKED VERSUS UNPROVOKED EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      HIGH-RISK GROUPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Rationale for preexposure prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      COUNSELING TRAVELERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Postexposure prophylaxis in resource-limited settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25404486\">",
"      DELAYS IN PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      COST OF POSTEXPOSURE PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2393351\">",
"      HOW SHOULD PROPHYLAXIS BE GIVEN?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29630012\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8328\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8328|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?6/36/6720\" title=\"algorithm 1\">",
"      Rabies postexposure prophylaxis algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8328|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/28/26051\" title=\"figure 1\">",
"      Rabies in the US",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8328|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/9/24735\" title=\"picture 1\">",
"      Bat bite",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8328|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/55/34683\" title=\"table 1\">",
"      Postexposure rabies guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/6/16492\" title=\"table 2\">",
"      Rabies preexposure guide",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/59/29624?source=related_link\">",
"      Clinical manifestations and diagnosis of rabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/15/22770?source=related_link\">",
"      Patient information: Animal bites (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/23/2418?source=related_link\">",
"      Patient information: Rabies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2393?source=related_link\">",
"      Rabies immune globulin and vaccine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20089="Overview of the management of overuse (chronic) tendinopathy";
var content_f19_39_20089=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the management of overuse (chronic) tendinopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Karim Khan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Alex Scott, PhD, RPT",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20089/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/39/20089/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overuse tendinopathy is a clinical syndrome characterized by chronic pain and tendon thickening. It commonly results from overuse and occurs in workers and recreational athletes. The majority of tendinopathies present in the chronic stage, with symptoms over three months in duration.",
"   </p>",
"   <p>",
"    Normally, tendon consists of tightly-packed collagen fibers. In tendinopathies, the collagen is in a state of disrepair, with proliferation and chronic irritation of neurovascular repair tissue in the tendon and its linings (paratendon and endotendon). This pattern is similar in most tendinopathies of the upper and lower extremity. Although complete or partial tendon ruptures may result from overuse, the treatment principles differ markedly from overuse tendinopathies and are therefore discussed separately. Paratendinopathies (eg, DeQuervain's tenosynovitis) are also distinct in that the primary pathology is the paratendon rather than the tendon proper and are not discussed here.",
"   </p>",
"   <p>",
"    The general treatment of chronic tendinopathy will be discussed here. The pathophysiology of tendinopathy and the management of specific tendinopathies are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=see_link\">",
"     \"Achilles tendinopathy and tendon rupture\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=see_link\">",
"     \"Epicondylitis (tennis and golf elbow)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21289?source=see_link\">",
"     \"Rotator cuff tendinopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATIENT HISTORY AND ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's history should elucidate what type of training or activity led to the tendinopathy and determine the level of function to which the patient aims to return.",
"   </p>",
"   <p>",
"    Validated, reliable, and simple functional assessment scores, such as the Victoria Institute of Sport Assessment (VISA) for patellar tendinopathy or VISA-A for Achilles tendinopathy, can help the clinician to grade symptoms and determine patient function (",
"    <a class=\"graphic graphic_figure graphicRef55215 \" href=\"UTD.htm?14/8/14467\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef76270 \" href=\"UTD.htm?2/11/2229\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Such scores also provide a useful means of monitoring recovery during rehabilitation. The VISA and VISA-A questionnaires can be completed in five minutes or less.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of approaches have been advocated for the treatment of tendinopathy. The most common and well supported strategies are presented here. Less well-established and investigational approaches are discussed below. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Investigational treatments'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The success of conservative treatment frequently depends upon a coordinated program of relative rest, correction of any underlying biomechanical faults, active rehabilitation, and a gradual return to tendon-loading activities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Activity modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who engage in provocative tendon-loading activities, it is important that coaches and employers be aware of the treatment plan, particularly the need to limit the volume and intensity of loads placed upon the injured tendon for a designated period.",
"   </p>",
"   <p>",
"    Normally, water in the extracellular matrix enables tendons to absorb force, making them more resistant to strain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. However, with sustained or repetitive loading, water is displaced or \"wrung out\" from the tendon, reducing its capacity to absorb force, thereby increasing tissue strain and susceptibility to injury. Thus, a load which is initially manageable for a tendon can produce damage with excessive repetition. This phenomenon is called \"tissue creep.\" To avoid tissue creep, training load increases and the return to functional activity should be gradual.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Biomechanical modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous studies have found associations between abnormal biomechanics or specific performance characteristics and the development of tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. As an example, computer users in one study were randomly assigned to use four different keyboard types [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/11\">",
"     11",
"    </a>",
"    ]. A reduction in tendon and other musculoskeletal complaints occurred after several months in patients using an ergonomic keyboard. According to a small prospective cohort study of auto workers, epicondylitis was strongly associated with the amount of time spent with the wrist out of neutral position during work [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, the biomechanics of the task responsible for the tendinopathy should be analyzed and optimized by an ergonomics specialist, a trained physiotherapist or kinesiologist, a knowledgeable sports medicine clinician, or a comparable expert. This treatment approach has not been studied in large, randomized trials but is supported by clinical experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Eccentric and heavy load exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;We believe that slow, controlled, progressive eccentric or other heavy load exercise should be the cornerstone of treatment for most cases of tendinopathy, including cases of Achilles, patellar, and lateral epicondyle tendinopathy. Eccentric exercise involves the careful application of a load (ie, muscular exertion) to a lengthening muscle; concentric exercise is the application of a load to a shortening (or contracting) muscle. The amount of loading prescribed should be individually tailored to the patient, taking into consideration their pain and fatigability, and keeping in mind the level of function to which they aim to return (ie, job or sporting demands). The progression should be gradual and carefully monitored.",
"   </p>",
"   <p>",
"    Although a systematic review notes a dearth of large randomized trials validating this approach [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/12\">",
"     12",
"    </a>",
"    ], several randomized and observational studies, performed primarily in patients with midportion Achilles tendinopathy, have found eccentric exercise to be an effective treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/13-19\">",
"     13-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some subsequent data suggests that heavy load concentric exercise performed in a slow, controlled manner (eg, six second contractions) may be equally beneficial, as determined by improved VISA scores [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/20\">",
"     20",
"    </a>",
"    ]. Further study is needed to confirm these findings.",
"   </p>",
"   <p>",
"    The strain from exercising with large tensile loads, moved in a slow, controlled manner, appears to stimulate tissue remodeling and normalization of tendon structure. Such exercise is often uncomfortable when performed, but done properly it should not cause severe pain or result in any worsening of symptoms (eg, pain or joint swelling the next day). During rehabilitative exercise, discomfort should be kept within moderate levels that do not suggest further injury.",
"   </p>",
"   <p>",
"    Specific instructions for implementing this therapeutic exercise program are beyond the scope of this review. The performance of eccentric exercise in the management of midportion Achilles tendinopathy and lateral epicondylitis are discussed separately; a basic treatment approach to tendinopathy is described below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=see_link\">",
"     \"Achilles tendinopathy and tendon rupture\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=see_link\">",
"     \"Epicondylitis (tennis and golf elbow)\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H22\">",
"     'Approach to treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Regardless of the tendon involved, it is crucial that a knowledgeable therapist supervise the patient embarking upon a heavy load rehabilitation regimen. The therapist must ensure that exercise technique is biomechanically sound, and the intensity and frequency of the program are appropriate to the patient and clinical circumstance [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Stretching",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stretching is useful for tendinopathy patients, both for symptomatic relief of muscle spasm and for corrective lengthening of shortened muscle-tendon units. Larger tendons, like the Achilles, may be stretched manually by a therapist, particularly when adhesions are suspected of limiting tendon movement. However, emphasis should be on the patient regularly performing stretching as part of a comprehensive rehabilitation program. These exercises should incorporate a steady hold to maximize muscle lengthening.",
"   </p>",
"   <p>",
"    Stretching has long been advocated to prevent tendinopathy. However, a systematic review found insufficient evidence to support or refute the use of stretching to prevent Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/22\">",
"     22",
"    </a>",
"    ]. Another systematic review found no clear evidence that stretching prevents sports-related injury [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the absence of definitive studies, most sports clinicians and physiotherapists routinely advocate stretching for prevention and treatment of tendinopathies. We suggest the following guidelines:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perform stretching exercises following activity, when muscles are warm; stretching before activity does not prevent injury and may cause transient decreases in strength [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]. Before activity, perform a gradual active warm-up that involves the major muscles to be used.",
"     </li>",
"     <li>",
"      Hold static stretches for 15 to 30 seconds; longer holds provide no additional benefit [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Stretch regularly (three to five days per week): flexibility gains from a single stretching session last 90 minutes, but gains from regular regimens persist for weeks after cessation [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alternatives to static stretching, such as proprioceptive neuromuscular facilitation (which incorporates brief periods of muscular contraction during stretching) and dynamic stretching (which involves active movement of the joint), may be beneficial, but studies are limited and further research is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ice or heat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controversy surrounding the use of ice or heat to treat chronic tendinopathy stems from historical debates about the role of inflammation in tendinopathy. One small study found that ice provided no benefit when added to a program of eccentric exercise to treat lateral epicondylalgia [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/27\">",
"     27",
"    </a>",
"    ]. Conversely, one small randomized trial found that heat (delivered by microwave diathermy) led to improved patient satisfaction with treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/28\">",
"     28",
"    </a>",
"    ]. Heat may be useful for treating muscle spasm associated with tendinopathy. We believe that neither ice nor heat are important treatments after the acute phase of injury, but both may serve as useful adjuncts during ongoing treatment of chronic tendinopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Joint mobilization and friction massage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is little evidence to support their use, certain manual techniques may serve as useful adjuncts to active rehabilitation. Clinical experience suggests that joint or muscle stiffness contributes to altered movement patterns and abnormal tendon loading, and this stiffness may be amenable to treatment with tissue mobilization techniques performed by an appropriately trained therapist.",
"   </p>",
"   <p>",
"    In one randomized trial, patients with chronic tendinopathy of the lateral epicondyle were randomly assigned to receive physiotherapy including joint mobilization (mobilization with movement, or MWM), corticosteroid injections, or a wait-and-see approach [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/29\">",
"     29",
"    </a>",
"    ]. Patients in the MWM group recovered more quickly than those in the wait-and-see group, and had significantly better long term outcomes than the corticosteroid group. Case studies also support the use of MWM for other upper extremity tendinopathies [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Historically, friction massage applied directly to the painful tendon (the Cyriax approach) was considered an important treatment for tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/31\">",
"     31",
"    </a>",
"    ]. Animal studies demonstrate that friction massage can increase tendon fibroblast activity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/32\">",
"     32",
"    </a>",
"    ]. However, a systematic review concluded that friction massage combined with other physiotherapy modalities does not consistently improve pain, grip strength, or functional status in tendinopathy patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/33\">",
"     33",
"    </a>",
"    ]. This is in line with our clinical experience and subsequent clinical trials, which show minimal benefit from friction massage compared with exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Anti-inflammatory medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of tendinopathies demonstrate minimal or no cellular inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/36\">",
"     36",
"    </a>",
"    ]. However, there may be a low level of biochemical inflammation present that contributes to pain and which can be reduced with antiinflammatory medications, particularly during the early phases of tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Nonsteroidal antiinflammatory drugs (NSAIDs)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral NSAIDs, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , may be helpful for short-term (eg, five to seven days) pain relief. We prefer to avoid long-term NSAID use in the treatment of tendinopathy given the absence of inflammation in most cases and the side effects associated with chronic use.",
"   </p>",
"   <p>",
"    The results of several small randomized trials support the use of topical NSAID gel or iontophoresis for short-term pain control [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. Topical NSAIDs may cause fewer systemic side effects than oral NSAIDs and systematic reviews have found no difference in long-term treatment outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Should patients require ongoing treatment with high doses of analgesics despite optimal conservative management, alternative diagnoses, such as partial tendon tear or inflammatory arthropathy, should be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effectiveness and risks associated with glucocorticoid treatment of tendinopathy appear to vary with the duration of symptoms and the mode of drug delivery (eg, local injection versus systemic treatment). Glucocorticoids may be useful in patients with acute tendinopathy. As an example, in one small randomized trial, glucocorticoids delivered by iontophoresis improved pain and stiffness in patients with Achilles tendinopathy of less than three months duration [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, in chronic tendinopathy, glucocorticoids are potentially harmful and we suggest they be avoided. Glucocorticoids inhibit collagen synthesis, possibly increasing the risk of tendon rupture, and have not been shown to improve long term outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/44\">",
"     44",
"    </a>",
"    ]. In patients with chronic symptoms of patellar or Achilles tendinopathy, glucocorticoid injections have not proven effective [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/20,45\">",
"     20,45",
"    </a>",
"    ]. A systematic review concluded that subacromial injections are effective at reducing symptoms, but the patients included suffered from a variety of pathologies (eg, adhesive capsulitis, labral injuries) so it is difficult to draw meaningful conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/46\">",
"     46",
"    </a>",
"    ]. According to another systematic review, glucocorticoid injections for lateral epicondylalgia (ie, epicondylitis) reduce pain initially, but ultimately increase recurrence rates and lead to worse long-term outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/42,47\">",
"     42,47",
"    </a>",
"    ]. A subsequent systematic review of randomized trials involving glucocorticoid injections for patients with lateral epicondylalgia or tendinopathy of the rotator cuff or Achilles tendon reported similar findings [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INVESTIGATIONAL TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of alternative injection therapies for chronic tendinopathy are under investigation. These therapies have not been compared with others in large controlled clinical trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19266642\">",
"    <span class=\"h2\">",
"     Topical glyceryl trinitrate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glyceryl trinitrate (GTN) patches placed directly over affected tendons deliver nitric oxide, a potent signaling molecule that stimulates collagen synthesis in tendon cells. Topical GTN is the subject of five randomized controlled trials, three of which demonstrated reductions in symptoms and improvement in function in patients with chronic tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/49-53\">",
"     49-53",
"    </a>",
"    ]. All three successful trials originate from the same research group and further validation of this treatment is needed.",
"   </p>",
"   <p>",
"    When using GTN, the skin should be monitored for signs of irritation, and the patient should be aware that dizziness and headaches are potential side effects. Nitric oxide therapy should be used in conjunction with an active rehabilitation regime. It is contraindicated in patients with hypotension, head injury, severe anemia, and those taking any other source of nitrates (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Prolotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolotherapy involves the injection of a substance, usually dextrose and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , intratendinously in order to stimulate a repair response. One small randomized controlled trial in patients with chronic epicondylalgia found that prolotherapy provided significant pain relief and improvement in grip strength 16 weeks after the initiation of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/54\">",
"     54",
"    </a>",
"    ]. A small, single blind randomized trial in chronic Achilles tendinopathy patients found greater improvement in VISA-A score at six weeks and 12 months with prolotherapy plus eccentric exercise compared to eccentric exercise alone [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/55\">",
"     55",
"    </a>",
"    ]. Observational studies report improvements in function and sonographic tendon appearance in patients with chronic Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Larger, randomized trials are needed to assess this treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Sclerotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic tendinopathy is associated with neovascularization of affected tendons. Injections of a sclerosing substance (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/6/110?source=see_link\">",
"     polidocanol",
"    </a>",
"    ) to reduce neovascularity have shown promise in a number of small clinical trials for chronic midportion Achilles and patellar tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Injections target abnormal blood vessels using ultrasound guidance. Pilot studies have demonstrated the feasibility of this technique for patients with de Quervain's tenosynovitis, flexor carpi ulnaris tendinopathy, supraspinatus tendinopathy and insertional Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/54,60-62\">",
"     54,60-62",
"    </a>",
"    ]. A retrospective observational study of 113 Achilles tendinopathy patients failed to confirm the initial reports of clinical benefit with polidocanol treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/63\">",
"     63",
"    </a>",
"    ]. Larger clinical trials are needed to determine the effectiveness of this treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Aprotinin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/52/6982?source=see_link\">",
"     Aprotinin",
"    </a>",
"    is a broad-spectrum protease and matrix metalloproteinase (MMP) inhibitor which may be injected peritendinously. One small randomized trial found no significant benefit from aprotinin injection in patients with Achilles tendinopathy, while a case series of 430 consecutive patients found that most experienced an improvement in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. Larger clinical trials are needed to determine the effectiveness of this treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Dry needling and autologous blood/platelet rich plasma injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound-guided dry needling and autologous blood injection may stimulate a healing response in chronic tendinopathy. However, studies of such therapies are limited by small sample size; larger clinical trials are needed, particularly in patients with chronic tendinopathy who have failed standard conservative treatment involving eccentric or heavy load exercise.",
"   </p>",
"   <p>",
"    In a prospective cohort study, high-level athletes were able to return to full sporting activity after receiving these treatments [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/67\">",
"     67",
"    </a>",
"    ]. Conversely, a small randomized controlled trial of patients with midportion Achilles tendinopathy demonstrated no benefit of platelet rich plasma (PRP) when added to an eccentric training program [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/68\">",
"     68",
"    </a>",
"    ]. Studies in patients with epicondylalgia (epicondylitis) are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=see_link&amp;anchor=H22#H22\">",
"     \"Epicondylitis (tennis and golf elbow)\", section on 'Platelet-rich plasma injections'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=see_link&amp;anchor=H23#H23\">",
"     \"Epicondylitis (tennis and golf elbow)\", section on 'Autologous blood injections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Acupuncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review found acupuncture to be of short-term benefit for the reduction of acute pain in patients with lateral epicondylalgia. However, there was insufficient evidence to support or refute its effect upon long-term outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/69\">",
"     69",
"    </a>",
"    ]. If used, acupuncture should be considered an adjunct to treatments that directly stimulate tendon repair. The use of acupuncture for analgesia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28457?source=see_link\">",
"     \"Acupuncture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Shock wave therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of clinical trials have examined the efficacy of shock wave therapy in tendinopathy, often using varying treatment parameters, and found marginal improvements over placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/70-73\">",
"     70-73",
"    </a>",
"    ]. Systematic reviews have concluded that there is insufficient evidence to recommend shock wave therapy for lateral epicondylalgia or for midportion Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/42,74\">",
"     42,74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1990765\">",
"    <span class=\"h2\">",
"     Ultrasound therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound (US) therapy has been available for several decades, but definitive evidence supporting its efficacy in treating tendinopathy is lacking. A systematic review of 13 randomized controlled trials (RCT) involving patellar tendinopathy patients concluded, based upon limited evidence, that",
"    <strong>",
"    </strong>",
"    US can likely be excluded as a treatment due to lack of efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/75\">",
"     75",
"    </a>",
"    ]. Another systematic review of RCTs of physical interventions for lateral elbow tendinopathy found insufficient evidence to support or refute the effectiveness of US as a lone treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/42\">",
"     42",
"    </a>",
"    ]. A single RCT comparing hyperthermia treatment to continuous US therapy in patients with either Achilles or patellar tendinopathy concluded that US treatment was inferior [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1990773\">",
"    <span class=\"h2\">",
"     Laser therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low level laser therapy (LLLT, also known as &ldquo;cold laser&rdquo;) has been available for many years, but convincing evidence of its clinical efficacy is lacking. Despite the development of LLLT dosing guidelines for the treatment of tendinopathies by the World Association of Laser Therapy (WALT), a systematic review of controlled clinical trials reported inconsistent results with 12 studies showing some benefit while 13 reported inconclusive results or no effect [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/76\">",
"     76",
"    </a>",
"    ]. Studies varied in quality and in the laser dosages used.",
"   </p>",
"   <p>",
"    A 2005 systematic review of studies of LLLT for patients with lateral epicondylalgia concluded that there was no clinically significant effect, either short or long-term, compared to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/42\">",
"     42",
"    </a>",
"    ]",
"    <em>",
"     .",
"    </em>",
"    Several controlled trials in which patients were randomly assigned to treatment with LLLT or placebo laser reported that active laser treatment did not improve outcomes beyond those achieved with eccentric exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. Another randomized trial reported no effect of LLLT (using WALT guidelines) as an adjunct to eccentric exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/79\">",
"     79",
"    </a>",
"    ]. However, some trials have reported significant symptom improvement in patients treated with active laser versus placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of chronic tendinopathies involves rehabilitation combined with conservative medical management. Surgical consultation is reasonable if there is no improvement after six months of diligent physical therapy using a well designed program in combination with adjunct medical treatments.",
"   </p>",
"   <p>",
"    A variety of operative treatments have been advocated, depending upon the location of the tendinopathy and the preferences of the surgeon. Referring clinicians should carefully assess the risks and benefits of surgery. A systematic review concluded that the degree of success claimed in surgical studies of tendinopathy repair correlates inversely with the quality of the study [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/81,82\">",
"     81,82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most procedures involve incising the paratendon and removing adhesions, followed by debridement of macroscopically degenerate tissue. Sometimes longitudinal incisions are made in the tendon, with the goal of promoting a repair response. A similar strategy of longitudinal incision and debridement may be achieved arthroscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/83-85\">",
"     83-85",
"    </a>",
"    ]. Resection or drilling of the tendon's attachment points have also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/86\">",
"     86",
"    </a>",
"    ]. Such procedures necessarily entail a prolonged recovery due to the time needed for tendon healing.",
"   </p>",
"   <p>",
"    Minimally invasive surgical procedures have been developed. The advantage of such procedures is that the tendon itself is not disturbed, so lengthy rehabilitation may be avoided. For the patellar tendon, an arthroscopic procedure may be performed by debriding the area of neovascularization on the posterior surface of the tendon until flow in the neovessels is no longer seen [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/87\">",
"     87",
"    </a>",
"    ]. For midportion Achilles tendinopathy, a similar approach involves stripping or debriding the neurovascular supply of the anterior surface of the tendon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     APPROACH TO TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tendinopathies are chronic injuries that are slow to resolve, often requiring months for complete healing. Patience and careful adherence to an active rehabilitation program emphasizing heavy load exercise and implemented in progressive steps are the keys to successful treatment. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Eccentric and heavy load exercise'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Clinicians should take adequate time to explain to patients that a prolonged recovery (often three to four months) is likely and that they should not be discouraged by ongoing symptoms during rehabilitation. Indeed, symptoms often worsen during the initial stages of exercise therapy as loads placed on the tendon increase, and this does not necessarily mean the tendon injury is being aggravated. Rather, we have found that educating patients about the benefits of mechanical load in stimulating tissue repair is important to successful treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maintaining a realistic view of rehabilitation is essential to patient engagement and treatment success. With challenging cases, careful oversight by a physiotherapist or exercise specialist is important to ensure that loads are heavy enough to promote healing but not so heavy as to exacerbate injury, impair function, cause excessive pain, or demoralize the patient.",
"   </p>",
"   <p>",
"    The treatment steps outlined immediately below are based upon the algorithm developed for Achilles tendinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20089/abstract/89\">",
"     89",
"    </a>",
"    ]. The exact steps may vary depending upon clinical circumstance, but the principles of controlled, progressive tendon loading and gradual resumption of activity remain central to any program. Time frames are approximate.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assess patient with mid-tendon pain: evaluate structures and joints that function in concert with involved tendon (ie, kinetic chain); examine peritendinous structures; rule out tendon rupture",
"     </li>",
"     <li>",
"      If tendinopathy is the leading diagnosis, begin eccentric heavy load exercise program under appropriate supervision (6 to 12 weeks); a short course of oral or topical analgesics may be helpful early in treatment",
"     </li>",
"     <li>",
"      If patient improves, continue exercise program (6 to 12 months)",
"     </li>",
"     <li>",
"      If no improvement, modify exercise program (adjust tendon load); reassess the kinetic chain, treating problems as indicated; may add adjunct therapies (eg, topical glyceryl trinitrate) (6 to 12 weeks)",
"     </li>",
"     <li>",
"      If no improvement, reassess biomechanics, modify exercise program, continue topical glyceryl trinitrate, and add adjunct therapies (eg, tissue mobilization) (6 to 12 weeks)",
"     </li>",
"     <li>",
"      If no improvement, continue exercise program, add pain-reducing adjunct treatments; depending upon clinician comfort and experience, and available resources, may add investigational treatments or opt for surgical referral (4 to 6 weeks)",
"     </li>",
"     <li>",
"      If no improvement, refer patient to orthopedic surgeon",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tendinopathy is a clinical syndrome characterized by chronic pain and tendon thickening. It commonly results from overuse and occurs in workers and athletes. Most patients present after three months of symptoms.",
"     </li>",
"     <li>",
"      The patient's history should elucidate the training or activity that led to the tendinopathy, and determine the level of function to which the patient aims to return. Validated functional assessment scores can help the clinician to grade symptoms and determine function.",
"     </li>",
"     <li>",
"      Abnormal biomechanics while performing common tasks (eg, running, jumping, walking, typing on a keyboard) often contribute to tendinopathy. Ideally, such potential abnormalities should be assessed by an expert and corrected wherever possible. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Patient history and assessment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Biomechanical modification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that rehabilitation programs to treat chronic tendinopathy emphasize eccentric or other heavy load exercise (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). A suggested treatment approach is described in the text. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Eccentric and heavy load exercise'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Approach to treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adjunct therapies may include stretching, tissue mobilization, ice or heat, and topical glyceryl trinitrate. A short course of antiinflammatory medication may be given at the onset of treatment. In chronic tendinopathy, glucocorticoids are potentially harmful and we suggest they be avoided (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). During rehabilitation it is important to limit the volume and intensity of loads placed upon the injured tendon outside of the therapeutic exercise program. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Stretching'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Ice or heat'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Joint mobilization and friction massage'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Anti-inflammatory medications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Activity modification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of alternative therapies for chronic tendinopathy are under investigation. These therapies, many of which involve intratendinous injections designed to stimulate a repair response, have not been compared in large clinical trials. Examples of alternative treatments include prolotherapy, sclerotherapy, autologous",
"      <span class=\"nowrap\">",
"       blood/platelet",
"      </span>",
"      rich plasma injection, and shock wave therapy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Investigational treatments'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial treatment of chronic tendinopathy consists of nonsurgical management. However, it is reasonable to obtain surgical consultation if after six months of diligent physical therapy using a well designed program in combination with adjunct medical treatments there has been no improvement in symptoms or function. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Indications for surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/1\">",
"      Robinson JM, Cook JL, Purdam C, et al. The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med 2001; 35:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/2\">",
"      Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport 1998; 1:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/3\">",
"      Puxkandl R, Zizak I, Paris O, et al. Viscoelastic properties of collagen: synchrotron radiation investigations and structural model. Philos Trans R Soc Lond B Biol Sci 2002; 357:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/4\">",
"      Wren TA, Lindsey DP, Beaupr&eacute; GS, Carter DR. Effects of creep and cyclic loading on the mechanical properties and failure of human Achilles tendons. Ann Biomed Eng 2003; 31:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/5\">",
"      Wellen J, Helmer KG, Grigg P, Sotak CH. Spatial characterization of T1 and T2 relaxation times and the water apparent diffusion coefficient in rabbit Achilles tendon subjected to tensile loading. Magn Reson Med 2005; 53:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/6\">",
"      Bisseling RW, Hof AL, Bredeweg SW, et al. Are the take-off and landing phase dynamics of the volleyball spike jump related to patellar tendinopathy? Br J Sports Med 2008; 42:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/7\">",
"      Kaufman KR, Brodine SK, Shaffer RA, et al. The effect of foot structure and range of motion on musculoskeletal overuse injuries. Am J Sports Med 1999; 27:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/8\">",
"      Lian &Oslash;, Refsnes PE, Engebretsen L, Bahr R. Performance characteristics of volleyball players with patellar tendinopathy. Am J Sports Med 2003; 31:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/9\">",
"      Svendsen SW, Gelineck J, Mathiassen SE, et al. Work above shoulder level and degenerative alterations of the rotator cuff tendons: a magnetic resonance imaging study. Arthritis Rheum 2004; 50:3314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/10\">",
"      Werner RA, Franzblau A, Gell N, et al. Predictors of persistent elbow tendonitis among auto assembly workers. J Occup Rehabil 2005; 15:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/11\">",
"      Tittiranonda P, Rempel D, Armstrong T, Burastero S. Effect of four computer keyboards in computer users with upper extremity musculoskeletal disorders. Am J Ind Med 1999; 35:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/12\">",
"      Woodley BL, Newsham-West RJ, Baxter GD. Chronic tendinopathy: effectiveness of eccentric exercise. Br J Sports Med 2007; 41:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/13\">",
"      Mafi N, Lorentzon R, Alfredson H. Superior short-term results with eccentric calf muscle training compared to concentric training in a randomized prospective multicenter study on patients with chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc 2001; 9:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/14\">",
"      Jonsson P, Alfredson H. Superior results with eccentric compared to concentric quadriceps training in patients with jumper's knee: a prospective randomised study. Br J Sports Med 2005; 39:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/15\">",
"      Martinez-Silvestrini JA, Newcomer KL, Gay RE, et al. Chronic lateral epicondylitis: comparative effectiveness of a home exercise program including stretching alone versus stretching supplemented with eccentric or concentric strengthening. J Hand Ther 2005; 18:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/16\">",
"      Roos EM, Engstr&ouml;m M, Lagerquist A, S&ouml;derberg B. Clinical improvement after 6 weeks of eccentric exercise in patients with mid-portion Achilles tendinopathy -- a randomized trial with 1-year follow-up. Scand J Med Sci Sports 2004; 14:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/17\">",
"      Selvanetti, A, et al. Med Sport (Roma) 2003; 56:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/18\">",
"      Silbernagel KG, Thome&eacute; R, Thome&eacute; P, Karlsson J. Eccentric overload training for patients with chronic Achilles tendon pain--a randomised controlled study with reliability testing of the evaluation methods. Scand J Med Sci Sports 2001; 11:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/19\">",
"      Svernl&ouml;v B, Adolfsson L. Non-operative treatment regime including eccentric training for lateral humeral epicondylalgia. Scand J Med Sci Sports 2001; 11:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/20\">",
"      Kongsgaard M, Kovanen V, Aagaard P, et al. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports 2009; 19:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/21\">",
"      Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med 2009; 43:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/22\">",
"      Park DY, Chou L. Stretching for prevention of Achilles tendon injuries: a review of the literature. Foot Ankle Int 2006; 27:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/23\">",
"      Thacker SB, Gilchrist J, Stroup DF, Kimsey CD Jr. The impact of stretching on sports injury risk: a systematic review of the literature. Med Sci Sports Exerc 2004; 36:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/24\">",
"      Shrier I. Does stretching improve performance? A systematic and critical review of the literature. Clin J Sport Med 2004; 14:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/25\">",
"      Roberts JM, Wilson K. Effect of stretching duration on active and passive range of motion in the lower extremity. Br J Sports Med 1999; 33:259.",
"     </a>",
"    </li>",
"    <li>",
"     Zebas CJ, Rivera MS. Retention of flexibility in selected joints after cessation of a stretching exercise program. In: Exercise Physiology: Current Selected Research, Dotson CO, Humphrey JH.  (Eds), AMS Press, New York 1985. p.181.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/27\">",
"      Manias P, Stasinopoulos D. A controlled clinical pilot trial to study the effectiveness of ice as a supplement to the exercise programme for the management of lateral elbow tendinopathy. Br J Sports Med 2006; 40:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/28\">",
"      Giombini A, Di Cesare A, Casciello G, et al. Hyperthermia at 434 MHz in the treatment of overuse sport tendinopathies: a randomised controlled clinical trial. Int J Sports Med 2002; 23:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/29\">",
"      Bisset L, Beller E, Jull G, et al. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ 2006; 333:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/30\">",
"      Backstrom KM. Mobilization with movement as an adjunct intervention in a patient with complicated de Quervain's tenosynovitis: a case report. J Orthop Sports Phys Ther 2002; 32:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/31\">",
"      Stasinopoulos D, Johnson MI. Cyriax physiotherapy for tennis elbow/lateral epicondylitis. Br J Sports Med 2004; 38:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/32\">",
"      Gehlsen GM, Ganion LR, Helfst R. Fibroblast responses to variation in soft tissue mobilization pressure. Med Sci Sports Exerc 1999; 31:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/33\">",
"      Brosseau L, Casimiro L, Milne S, et al. Deep transverse friction massage for treating tendinitis. Cochrane Database Syst Rev 2002; :CD003528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/34\">",
"      Stasinopoulos D, Stasinopoulos I. Comparison of effects of exercise programme, pulsed ultrasound and transverse friction in the treatment of chronic patellar tendinopathy. Clin Rehabil 2004; 18:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/35\">",
"      Stasinopoulos D, Stasinopoulos I. Comparison of effects of Cyriax physiotherapy, a supervised exercise programme and polarized polychromatic non-coherent light (Bioptron light) for the treatment of lateral epicondylitis. Clin Rehabil 2006; 20:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/36\">",
"      Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology (Oxford) 2006; 45:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/37\">",
"      Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med 2006; 40:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/38\">",
"      Burnham R, Gregg R, Healy P, Steadward R. The effectiveness of topical diclofenac for lateral epicondylitis. Clin J Sport Med 1998; 8:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/39\">",
"      Demirta RN, Oner C. The treatment of lateral epicondylitis by iontophoresis of sodium salicylate and sodium diclofenac. Clin Rehabil 1998; 12:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/40\">",
"      Mazi&egrave;res B, Rouanet S, Guillon Y, et al. Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study. J Rheumatol 2005; 32:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/41\">",
"      McLauchlan GJ, Handoll HH. Interventions for treating acute and chronic Achilles tendinitis. Cochrane Database Syst Rev 2001; :CD000232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/42\">",
"      Bisset L, Paungmali A, Vicenzino B, Beller E. A systematic review and meta-analysis of clinical trials on physical interventions for lateral epicondylalgia. Br J Sports Med 2005; 39:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/43\">",
"      Neeter C, Thome&eacute; R, Silbernagel KG, et al. Iontophoresis with or without dexamethazone in the treatment of acute Achilles tendon pain. Scand J Med Sci Sports 2003; 13:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/44\">",
"      Ismail AM, Balakrishnan R, Rajakumar MK, Lumpur K. Rupture of patellar ligament after steroid infiltration. Report of a case. J Bone Joint Surg Br 1969; 51:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/45\">",
"      Shrier I, Matheson GO, Kohl HW 3rd. Achilles tendonitis: are corticosteroid injections useful or harmful? Clin J Sport Med 1996; 6:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/46\">",
"      Arroll B, Goodyear-Smith F. Corticosteroid injections for painful shoulder: a meta-analysis. Br J Gen Pract 2005; 55:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/47\">",
"      Smidt N, van der Windt DA, Assendelft WJ, et al. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet 2002; 359:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/48\">",
"      Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet 2010; 376:1751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/49\">",
"      Kane TP, Ismail M, Calder JD. Topical glyceryl trinitrate and noninsertional Achilles tendinopathy: a clinical and cellular investigation. Am J Sports Med 2008; 36:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/50\">",
"      Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial. Am J Sports Med 2003; 31:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/51\">",
"      Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy. A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 2004; 86-A:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/52\">",
"      Paoloni JA, Appleyard RC, Nelson J, Murrell GA. Topical glyceryl trinitrate application in the treatment of chronic supraspinatus tendinopathy: a randomized, double-blinded, placebo-controlled clinical trial. Am J Sports Med 2005; 33:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/53\">",
"      Steunebrink M, Zwerver J, Brandsema R, et al. Topical glyceryl trinitrate treatment of chronic patellar tendinopathy: a randomised, double-blind, placebo-controlled clinical trial. Br J Sports Med 2013; 47:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/54\">",
"      Scarpone M, Rabago DP, Zgierska A, et al. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med 2008; 18:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/55\">",
"      Yelland MJ, Sweeting KR, Lyftogt JA, et al. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med 2011; 45:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/56\">",
"      Maxwell NJ, Ryan MB, Taunton JE, et al. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. AJR Am J Roentgenol 2007; 189:W215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/57\">",
"      Ryan M, Wong A, Taunton J. Favorable outcomes after sonographically guided intratendinous injection of hyperosmolar dextrose for chronic insertional and midportion achilles tendinosis. AJR Am J Roentgenol 2010; 194:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/58\">",
"      Alfredson H, Ohberg L. Neovascularisation in chronic painful patellar tendinosis--promising results after sclerosing neovessels outside the tendon challenge the need for surgery. Knee Surg Sports Traumatol Arthrosc 2005; 13:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/59\">",
"      Alfredson H, Ohberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc 2005; 13:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/60\">",
"      Alfredson H, Harstad H, Haugen S, Ohberg L. Sclerosing polidocanol injections to treat chronic painful shoulder impingement syndrome-results of a two-centre collaborative pilot study. Knee Surg Sports Traumatol Arthrosc 2006; 14:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/61\">",
"      Knobloch K, Spies M, Busch KH, Vogt PM. Sclerosing therapy and eccentric training in flexor carpi radialis tendinopathy in a tennis player. Br J Sports Med 2007; 41:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/62\">",
"      Ohberg L, Alfredson H. Sclerosing therapy in chronic Achilles tendon insertional pain-results of a pilot study. Knee Surg Sports Traumatol Arthrosc 2003; 11:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/63\">",
"      van Sterkenburg MN, de Jonge MC, Sierevelt IN, van Dijk CN. Less promising results with sclerosing ethoxysclerol injections for midportion achilles tendinopathy: a retrospective study. Am J Sports Med 2010; 38:2226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/64\">",
"      Brown R, Orchard J, Kinchington M, et al. Aprotinin in the management of Achilles tendinopathy: a randomised controlled trial. Br J Sports Med 2006; 40:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/65\">",
"      Capasso, G, Testa, V, Maffulli, N, Bifulco, G. Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes: a prospective randomized study. Sports Exercise Injury 1997; 3:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/66\">",
"      Orchard J, Massey A, Brown R, et al. Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin. Clin Orthop Relat Res 2008; 466:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/67\">",
"      James SL, Ali K, Pocock C, et al. Ultrasound guided dry needling and autologous blood injection for patellar tendinosis. Br J Sports Med 2007; 41:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/68\">",
"      de Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 2010; 303:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/69\">",
"      Green S, Buchbinder R, Barnsley L, et al. Acupuncture for lateral elbow pain. Cochrane Database Syst Rev 2002; :CD003527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/70\">",
"      Buchbinder R, Green S, White M, et al. Shock wave therapy for lateral elbow pain. Cochrane Database Syst Rev 2002; :CD003524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/71\">",
"      Chung B, Wiley JP. Effectiveness of extracorporeal shock wave therapy in the treatment of previously untreated lateral epicondylitis: a randomized controlled trial. Am J Sports Med 2004; 32:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/72\">",
"      Costa ML, Shepstone L, Donell ST, Thomas TL. Shock wave therapy for chronic Achilles tendon pain: a randomized placebo-controlled trial. Clin Orthop Relat Res 2005; 440:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/73\">",
"      Lebrun CM. Low-dose extracorporeal shock wave therapy for previously untreated lateral epicondylitis. Clin J Sport Med 2005; 15:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/74\">",
"      Scott A, Huisman E, Khan K. Conservative treatment of chronic Achilles tendinopathy. CMAJ 2011; 183:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/75\">",
"      Larsson ME, K&auml;ll I, Nilsson-Helander K. Treatment of patellar tendinopathy--a systematic review of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc 2012; 20:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/76\">",
"      Tumilty S, Munn J, McDonough S, et al. Low level laser treatment of tendinopathy: a systematic review with meta-analysis. Photomed Laser Surg 2010; 28:3.",
"     </a>",
"    </li>",
"    <li>",
"     Tumilty S, Munn J, Haxby Abbot J, et al. Laser therapy in the treatment of Achilles tendinopathy: A randomized controlled trial. In: LASER FLORENCE 2009: A Gallery Through the Laser Medicine World (AIP Conference Proceedings), Longo L.  (Ed), American Institute of Physics, Melville 2010. Vol 1226, p.163.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/78\">",
"      Stasinopoulos D, Stasinopoulos I, Pantelis M, Stasinopoulou K. Comparing the effects of exercise program and low-level laser therapy with exercise program and polarized polychromatic non-coherent light (bioptron light) on the treatment of lateral elbow tendinopathy. Photomed Laser Surg 2009; 27:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/79\">",
"      Tumilty S, McDonough S, Hurley DA, Baxter GD. Clinical effectiveness of low-level laser therapy as an adjunct to eccentric exercise for the treatment of Achilles' tendinopathy: a randomized controlled trial. Arch Phys Med Rehabil 2012; 93:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/80\">",
"      Emanet SK, Altan LI, Yurtkuran M. Investigation of the effect of GaAs laser therapy on lateral epicondylitis. Photomed Laser Surg 2010; 28:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/81\">",
"      Coleman BD, Khan KM, Maffulli N, et al. Studies of surgical outcome after patellar tendinopathy: clinical significance of methodological deficiencies and guidelines for future studies. Victorian Institute of Sport Tendon Study Group. Scand J Med Sci Sports 2000; 10:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/82\">",
"      Tallon C, Coleman BD, Khan KM, Maffulli N. Outcome of surgery for chronic Achilles tendinopathy. A critical review. Am J Sports Med 2001; 29:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/83\">",
"      Maffulli N, Testa V, Capasso G, et al. Surgery for chronic Achilles tendinopathy yields worse results in nonathletic patients. Clin J Sport Med 2006; 16:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/84\">",
"      Nelen G, Martens M, Burssens A. Surgical treatment of chronic Achilles tendinitis. Am J Sports Med 1989; 17:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/85\">",
"      Nirschl RP, Pettrone FA. Tennis elbow. The surgical treatment of lateral epicondylitis. J Bone Joint Surg Am 1979; 61:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/86\">",
"      Lorbach O, Diamantopoulos A, Paessler HH. Arthroscopic resection of the lower patellar pole in patients with chronic patellar tendinosis. Arthroscopy 2008; 24:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/87\">",
"      Willberg L, Sunding K, Ohberg L, et al. Treatment of Jumper's knee: promising short-term results in a pilot study using a new arthroscopic approach based on imaging findings. Knee Surg Sports Traumatol Arthrosc 2007; 15:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/88\">",
"      Khan KM, Scott A. Mechanotherapy: how physical therapists' prescription of exercise promotes tissue repair. Br J Sports Med 2009; 43:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20089/abstract/89\">",
"      Alfredson H, Cook J. A treatment algorithm for managing Achilles tendinopathy: new treatment options. Br J Sports Med 2007; 41:211.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 230 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-4B2100FB5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20089=[""].join("\n");
var outline_f19_39_20089=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATIENT HISTORY AND ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Activity modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Biomechanical modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Eccentric and heavy load exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Stretching",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ice or heat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Joint mobilization and friction massage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Anti-inflammatory medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Nonsteroidal antiinflammatory drugs (NSAIDs)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INVESTIGATIONAL TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19266642\">",
"      Topical glyceryl trinitrate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Prolotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Sclerotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Aprotinin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Dry needling and autologous blood/platelet rich plasma injection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Acupuncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Shock wave therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1990765\">",
"      Ultrasound therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1990773\">",
"      Laser therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      INDICATIONS FOR SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      APPROACH TO TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/230\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/230|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/8/14467\" title=\"figure 1\">",
"      VISA questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/11/2229\" title=\"figure 2\">",
"      VISA A questionnaire",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32537?source=related_link\">",
"      Achilles tendinopathy and tendon rupture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28457?source=related_link\">",
"      Acupuncture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=related_link\">",
"      Epicondylitis (tennis and golf elbow)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21289?source=related_link\">",
"      Rotator cuff tendinopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20090="Evaluation of chest pain in the emergency department";
var content_f19_39_20090=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of chest pain in the emergency department",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Judd E Hollander, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Maureen Chase, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Robert S Hockberger, MD, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/39/20090/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/39/20090/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain accounts for approximately six million annual visits to emergency departments (ED) in the United States (US), making chest pain the second most common complaint [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients present with a spectrum of signs and symptoms reflecting the many potential etiologies of chest pain. Diseases of the heart, aorta, lungs, esophagus, stomach, mediastinum, pleura, and abdominal viscera may all cause chest discomfort.",
"   </p>",
"   <p>",
"    Clinicians in the ED focus on the immediate recognition and exclusion of life-threatening causes of chest pain. Patients with life threatening etiologies for chest pain may appear deceptively well, manifesting neither vital sign nor physical examination abnormalities.",
"   </p>",
"   <p>",
"    This topic review will discuss life-threatening and common causes of chest pain, and provide an approach to the evaluation of chest pain patients in the ED. Detailed discussions of specific causes of chest pain, including the management of a suspected acute coronary syndrome in the ED are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link\">",
"     \"Overview of acute pulmonary embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25449?source=see_link\">",
"     \"Management of aortic dissection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"     \"Primary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link\">",
"     \"Secondary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link\">",
"     \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of chest pain that pose an immediate threat to life include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute coronary syndrome",
"     </li>",
"     <li>",
"      Aortic dissection",
"     </li>",
"     <li>",
"      Pulmonary embolism",
"     </li>",
"     <li>",
"      Tension pneumothorax",
"     </li>",
"     <li>",
"      Pericardial tamponade",
"     </li>",
"     <li>",
"      Mediastinitis (eg, Esophageal rupture)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute coronary syndrome &ndash; Coronary vascular disease remains the leading killer of adults in developed countries. The 28 day case mortality rate for an acute coronary syndrome (ACS) among patients in developed nations is approximately 10 percent, but varies with the severity of disease and the treatment provided. Less than 15 to 30 percent of patients who present to the emergency department (ED) with nontraumatic chest pain have ACS, which includes myocardial infarction and unstable angina [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=see_link\">",
"       \"Epidemiology of coronary heart disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31961?source=see_link\">",
"       \"Evaluation of patients with chest pain at low or intermediate risk for acute coronary syndrome\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      ACS results from atherosclerotic plaque rupture and thrombus formation via the adhesion, activation, and aggregation of platelets. Coronary blood flow is reduced and myocardial ischemia occurs. The degree and duration of the oxygen supply-demand mismatch determines whether the patient develops reversible myocardial ischemia without injury (unstable angina) or myocardial ischemia with injury (myocardial infarction). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4167?source=see_link\">",
"       \"The role of platelets in coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic dissection &ndash; The incidence of aortic dissection is estimated at 3 per 100,000 patients per year. This number may be a gross underestimation of the true incidence as many patients die prior to diagnosis. Aortic dissection most commonly affects patients with systemic hypertension in their seventh decade of life. Dissection typically begins with a tear in the inner layer of the aortic wall allowing blood to track between the intima (inner layer) and media (middle layer). Pulsatile blood flow causes propagation of the dissection with subsequent obstruction of branch arteries and ischemic injury to areas perfused by those vessels. In approximately 13 percent of cases, no intimal tear is identified. Such patients have an acute aortic syndrome likely caused by bleeding of the vasa vasorum with intramural hematoma formation in the wall of the aorta. The clinical picture is similar to classic aortic dissection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary embolism &ndash; The incidence of pulmonary embolism (PE) is estimated at over 1 in 1000 patients, but the diagnosis is often missed and the incidence may be higher. Mortality rates vary widely based upon comorbid conditions and the size of the embolus. Early diagnosis and treatment dramatically reduce mortality. Pulmonary embolism occurs when a dislodged venous clot migrates through the right side of the heart and becomes lodged at the branch point of the pulmonary arteries (saddle embolus) or more distally. Occlusion of pulmonary blood flow results in pulmonary hypertension, right ventricular dysfunction, poor gas exchange, and ultimately parenchymal infarction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link\">",
"       \"Overview of acute pulmonary embolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumothorax &ndash; Pneumothorax can occur following trauma or pulmonary procedures. It also occurs spontaneously in patients with underlying lung disease (secondary pneumothorax) and without (primary pneumothorax). Patients with primary spontaneous pneumothorax tend to be younger males who are tall and thin. Secondary spontaneous pneumothorax occurs with greatest frequency in patients with chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Regardless of etiology, the accumulation of air in the pleural space can lead to tension pneumothorax with compression of the mediastinum, causing rapid clinical deterioration and death if unrecognized. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"       \"Primary spontaneous pneumothorax in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mediastinitis &ndash; Common causes of mediastinitis include odontogenic infections, esophageal perforation, and iatrogenic complications of cardiac surgery or upper gastrointestinal and airway procedures. Mortality for patients with mediastinitis remains high (14 to 42 percent), even when treated with operative debridement and antibiotics [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/4-7\">",
"       4-7",
"      </a>",
"      ]. Delays in diagnosis further increase mortality. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link\">",
"       \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pericardial tamponade &ndash; Pericardial tamponade occurs when there is accumulation of pericardial fluid under pressure, leading to impaired cardiac filling. Tamponade covers a spectrum of clinical severity. Some patients have mild compromise, while others develop a severe compromise in cardiac filling, producing a picture resembling cardiogenic shock that requires emergent reduction in pericardial pressure by pericardiocentesis. Tamponade may occur with aortic dissection, after thoracic trauma, or as a consequence of acute pericarditis from infection, malignancy, uremia, or some other cause. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"       \"Cardiac tamponade\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Common conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Below is a brief description of diseases that commonly occur among emergency department (ED) patients complaining of chest pain. Gastrointestinal problems, such as gastroesophageal reflux disease, comprise a significant number of such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/2\">",
"     2",
"    </a>",
"    ]. Common causes of chest pain that are not life-threatening are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/0/26634?source=see_link\">",
"     \"Differential diagnosis of chest pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac causes &ndash; Acute heart failure is frequently associated with chest discomfort. Patients with stable angina can usually identify their anginal chest pain and relay a history of exertional triggers. Valvular heart disease, such as mitral valve prolapse and aortic stenosis, may cause chest discomfort, which may signify worsening valvular function. Infectious or inflammatory causes of chest discomfort include pericarditis, myocarditis, and endocarditis. Accumulation of pericardial fluid can result in chest discomfort as can cardiac arrhythmias, especially if coronary blood flow is impaired. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7544?source=see_link\">",
"       \"Evaluation of acute decompensated heart failure\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=see_link\">",
"       \"Overview of the care of patients with stable ischemic heart disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"       \"Clinical features and evaluation of aortic stenosis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3476?source=see_link\">",
"       \"Mitral valve prolapse syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"       \"Diagnostic approach to infective endocarditis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=see_link\">",
"       \"Clinical presentation and diagnostic evaluation of acute pericarditis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"       \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Pulmonary/pleural",
"      </span>",
"      causes &ndash; Respiratory infections, such as pneumonia, tracheitis, and bronchitis, are frequently accompanied by chest discomfort and cough. Chest tightness is a common complaint with asthma exacerbations. A number of disease processes can result in increased pulmonary arterial pressures and resultant right sided heart dysfunction (cor pulmonale). Pulmonary malignancy can cause chest pain particularly if there is pleural involvement. Chest heaviness or discomfort may be noted with pleural effusions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link\">",
"       \"Diagnostic approach to community-acquired pneumonia in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/56/5002?source=see_link\">",
"       \"Treatment of acute exacerbations of asthma in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=see_link\">",
"       \"Cor pulmonale\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"       \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gastrointestinal causes &ndash; Gastroesophageal reflux and esophageal spasm, rupture (Boerhaave's syndrome), or inflammation can all present as chest discomfort. A sliding hiatal hernia may result in chest pain. Pain from pancreatitis can be referred to the chest. Gastrointestinal causes account for the symptoms of a sizable number of patients who complain of chest pain and do not have an acute coronary syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=see_link\">",
"       \"Clinical manifestations and diagnosis of gastroesophageal reflux in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=see_link\">",
"       \"Chest pain of esophageal origin\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link\">",
"       \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Musculoskeletal causes &ndash; Musculoskeletal causes of chest pain include rib contusions and fractures, intercostal muscle strains, and costochondritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=see_link\">",
"       \"Major causes of musculoskeletal chest pain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psychiatric causes &ndash; Patients with panic attack often complain of chest tightness and a sense of impending doom. This remains a diagnosis of exclusion in the ED. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7305?source=see_link\">",
"       \"Pharmacotherapy for panic disorder\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other conditions &ndash; Less commonly encountered conditions that may manifest as chest pain include: herpes zoster, referred pain, and pain associated with various inflammatory conditions and collagen vascular diseases, including lupus, sarcoid, scleroderma, Kawasaki's disease, polyarteritis nodosa, and Takayasu's arteritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/6/21608?source=see_link\">",
"       \"Postherpetic neuralgia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracic organs share afferent nervous system pathways. This creates significant overlap in the symptoms patients experience when thoracic organs develop disease, and makes it difficult to distinguish which organ system is involved purely on the basis of history. Patient descriptions of their symptoms can be helpful in some instances, but emergency clinicians must guard against premature diagnostic closure based upon history. Several studies demonstrate that so-called \"atypical\" presentations occur more often than was previously thought and misinterpretation of such presentations increases the risk for misdiagnosis and adverse outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obtain a detailed history of the patient's chest pain, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Onset of pain (eg, abrupt or gradual)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Provocation/Palliation",
"      </span>",
"      (which activities provoke pain; which alleviate pain)",
"     </li>",
"     <li>",
"      Quality of pain (eg, sharp, squeezing, pleuritic)",
"     </li>",
"     <li>",
"      Radiation (eg, shoulder, jaw, back)",
"     </li>",
"     <li>",
"      Site of pain (eg, substernal, chest wall, diffuse, localized)",
"     </li>",
"     <li>",
"      Timing (eg, constant or episodic, duration of episodes, when pain began)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ask about prior diagnostic studies (eg, stress test or coronary CT angiography) for similar symptoms or prior procedures (eg, cardiac catheterization). Ask whether the discomfort is similar to prior illness. Associated symptoms, such as nausea, vomiting, diaphoresis, dyspnea, syncope, and palpitations, can be helpful. Preceding or concomitant symptoms, such as fever or peripheral edema, may point to a diagnosis. Ask about risk factors for life-threatening illness, especially acute coronary syndrome, aortic dissection, and pulmonary embolus, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Comorbidities: hypertension, diabetes mellitus, peripheral vascular disease, malignancy",
"     </li>",
"     <li>",
"      Recent events: trauma, major surgery or medical procedures (eg, endoscopy), periods of immobilization (eg, long plane ride)",
"     </li>",
"     <li>",
"      Other factors: cocaine use, cigarette use, family history",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Onset of pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of the onset of chest pain can help to narrow the differential diagnosis. Pain that starts suddenly and is severe at onset is associated with aortic dissection, pneumothorax, and pulmonary embolism. Abrupt onset of pain was reported in 85 percent of patients in one registry of patients with acute aortic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/10\">",
"     10",
"    </a>",
"    ]. Chest pain associated with pulmonary embolism can begin suddenly, but may worsen over time. Nontraumatic pneumothorax most often occurs suddenly at rest, without any precipitating event. A history of forceful vomiting preceding symptoms in a toxic appearing patient raises concern for a ruptured esophagus and mediastinitis. However, a significant portion of patients who rupture their esophagus give no history of vomiting and presentations vary [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversely, discomfort from an acute coronary syndrome typically starts gradually and worsens with exertion. With stable angina, discomfort occurs only when activity creates an oxygen demand that outstrips supply limitations imposed by a fixed atherosclerotic lesion. This occurs at relatively predictable points and changes slowly over time. Unstable angina represents an abrupt change from baseline functioning, which may manifest as discomfort that begins at lower levels of exercise or at rest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pain quality and location",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients often describe the symptoms of an",
"    <strong>",
"     acute coronary syndrome",
"    </strong>",
"    (ACS) as discomfort rather than pain. The discomfort may be a pressure, heaviness, tightness, fullness, or squeezing. Ischemia is less likely if the discomfort is knifelike, sharp, pleuritic, or positional. The classic location is substernal or in the left chest, and radiation to the arm, neck, jaw, back, abdomen, or shoulders may occur. Pain that radiates to the shoulders or occurs with exertion significantly increases the relative risk for ACS.",
"   </p>",
"   <p>",
"    Relief of pain following the administration of sublingual",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    does",
"    <strong>",
"     not",
"    </strong>",
"    reliably distinguish between cardiac ischemia and noncardiac causes of chest pain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Beware of \"atypical\" presentations of ACS, which are common and occur more often in the elderly, diabetics, and women. Patients with \"atypical\" symptoms (eg, dyspnea, weakness) associated with their myocardial infarction fare worse than patients who experience typical symptoms, likely due to delays in diagnosis and treatment. These issues are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H9#H9\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H14#H14\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Atypical symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An aortic dissection most often presents with the sudden onset of sharp, severe pain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/10,16\">",
"     10,16",
"    </a>",
"    ]. Patients may describe the pain as tearing, or ripping. However, according to the International Registry of Acute Aortic Dissection (IRAD), presentations can be diverse and classic findings absent. The pain most often occurs in the chest, but can begin in the back, and may migrate or radiate into other areas of the chest, back, or abdomen, depending upon the portion of the aorta involved and the extent of the dissection. Sharp pain may also accompany pulmonary embolism, pneumothorax, or pericarditis.",
"   </p>",
"   <p>",
"    A",
"    <strong>",
"     pulmonary embolism",
"    </strong>",
"    (PE) can create different kinds of pain, or painless dyspnea. Pain associated with PE may worsen with deep inspiration, and may localize to the chest wall. Patients with",
"    <strong>",
"     pneumothorax",
"    </strong>",
"    report ipsilateral chest pain which may initially be sharp and pleuritic but may become dull or achy over time. The discomfort of",
"    <strong>",
"     pericarditis",
"    </strong>",
"    is classically positional: worse when lying supine and relieved somewhat when leaning forward. It may also worsen with deep inspiration.",
"   </p>",
"   <p>",
"    Sharp, well-localized pain reproduced with movement or palpation of the chest wall is characteristic of",
"    <strong>",
"     musculoskeletal",
"    </strong>",
"    causes. Often the patient relates a history of trauma or strenuous activity prior to developing pain.",
"   </p>",
"   <p>",
"    Burning pain in the chest and epigastrium is commonly associated with gastrointestinal causes.",
"    <strong>",
"     Esophageal rupture",
"    </strong>",
"    can cause chest",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abdominal pain. Cardiac disease can cause identical symptoms, however, and emergency clinicians must avoid prematurely attributing such symptoms to gastrointestinal disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Associated symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diaphoresis, nausea, and vomiting frequently accompany chest discomfort associated with acute coronary syndrome (ACS), but are not predictive of ACS [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/17\">",
"     17",
"    </a>",
"    ]. Elderly patients with ACS may only complain of symptoms other than chest pain, such as dyspnea, weakness, altered mental status, or syncope. Symptoms, such as diaphoresis and nausea, may also occur with nonischemic chest pain, including aortic dissection, pulmonary embolus, acute heart failure, and esophageal spasm.",
"   </p>",
"   <p>",
"    Aortic dissection has a wide range of potential associated symptoms, depending on the arterial branches involved, which may confound the diagnosis (",
"    <a class=\"graphic graphic_table graphicRef77441 \" href=\"UTD.htm?36/58/37803\">",
"     table 1",
"    </a>",
"    ). According to one review, syncope accompanies 13 percent of dissections involving the ascending aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/18\">",
"     18",
"    </a>",
"    ]. Neurological symptoms, ranging from hoarseness to paraplegia and altered mental status, occur in 18 to 30 percent of patients with aortic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/18\">",
"     18",
"    </a>",
"    ]. ACS can occur when the dissection involves the coronary arteries.",
"   </p>",
"   <p>",
"    Shortness of breath frequently accompanies pulmonary causes of chest pain and may be the predominant symptom in pulmonary embolus, pneumothorax, and pneumonia. Tachypnea is common with PE and may be accompanied by wheezing and fever. Young healthy patients may manifest only a relative tachypnea or tachycardia despite the presence of pneumonia or pulmonary embolism. Dyspnea is often the only complaint among elderly patients with ACS.",
"   </p>",
"   <p>",
"    Cough, syncope, and hemoptysis may occur with pulmonary embolism or valvular heart disease (particularly mitral stenosis), although cough and hemoptysis are more common with bronchitis, pharyngitis, or exacerbations of COPD. Dyspnea and cough may accompany pericardial and pleural effusions regardless of etiology.",
"   </p>",
"   <p>",
"    Preceding or concomitant pain and swelling in an extremity suggests deep venous thrombosis (DVT) complicated by pulmonary embolism. DVT occurs most often in the lower extremities but clots may also originate in the upper extremities and the large veins of the pelvis, where they may produce bilateral lower extremity swelling if the inferior vena cava becomes occluded.",
"   </p>",
"   <p>",
"    Nausea and belching frequently accompany gastrointestinal causes of chest pain, but can also occur in patients with inferior myocardial infarction. Fever raises concern for infectious causes, but is also associated with pericarditis, myocarditis, and rarely acute myocardial infarction. A low-grade fever may accompany pulmonary embolus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for",
"    <strong>",
"     acute coronary syndrome",
"    </strong>",
"    (ACS) include: male sex, age over 55 years, family history of coronary artery disease, diabetes mellitus, hypercholesterolemia, hypertension, and tobacco use. Cardiac risk factors are poor predictors of acute risk in symptomatic emergency department (ED) patients, as the presence of chest pain outweighs their predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/19\">",
"     19",
"    </a>",
"    ]. The absence of cardiac risk factors does not identify patients that can safely be discharged from the ED. Cocaine or amphetamine use raises concern for ACS regardless of other risk factors. Cocaine increases the metabolic demands of the heart via its stimulant effects, and also causes coronary artery vasoconstriction and promotes thrombus formation in patients who may otherwise be at low risk for ACS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=see_link\">",
"     \"Cocaine: Acute intoxication\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of",
"    <strong>",
"     aortic dissection",
"    </strong>",
"    must be considered in patients with inherited connective tissue diseases and other diseases that weaken the structural architecture of the aortic wall. Patients younger than 40 years of age with Marfan's syndrome, bicuspid aortic valve, cocaine use, or pregnancy are at risk for aortic dissection. Other factors that predispose to aortic dissection include: a history of previous aortic surgery and recent cardiac surgery or catheterization. Aortic dissection occurs most often in patients with systemic hypertension and advanced age, but so do many other causes of chest pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations and diagnosis of aortic dissection\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An increased risk for deep vein thrombosis and subsequent",
"    <strong>",
"     pulmonary embolus",
"    </strong>",
"    exists among patients with a recent history of prolonged immobilization (eg, long distance travel), surgery (particularly an orthopedic procedure of the lower extremity lasting more than 30 minutes), central venous catheterization, or trauma. Also at risk are pregnant patients, patients with cancer, lung, or chronic heart disease, and those with a personal or family history of hypercoagulability. Use of oral contraceptives or chemotherapeutic agents that raise serum levels of estrogen or progestin also confers increased risk. A significant number of patients with PE may have no identifiable risk factor at the time of diagnosis, but subsequent testing reveals a predisposition for venous thrombosis (eg, Factor V Leiden mutation). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of acute pulmonary embolism\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tobacco use raises patient risk for cardiovascular and pulmonary disease. Smoking is also an independent risk factor for spontaneous",
"    <strong>",
"     pneumothorax",
"    </strong>",
"    , regardless of underlying lung disease. A high prevalence of spontaneous pneumothorax exists among HIV infected patients with pneumocystis carinii (P. jiroveci) pneumonia. Young females with endometriosis may experience menses-related pneumothoraces, also referred to as catamenial pneumothorax, if pleural involvement exists [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/20\">",
"     20",
"    </a>",
"    ]. Activities, such as SCUBA diving, can precipitate a spontaneous pneumothorax and air travel may precipitate recurrence in patients with an incompletely healed pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link&amp;anchor=H3#H3\">",
"     \"Primary spontaneous pneumothorax in adults\", section on 'Risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20678?source=see_link\">",
"     \"Pneumothorax in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4633?source=see_link\">",
"     \"Complications of scuba diving\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35271?source=see_link\">",
"     \"Pneumothorax and air travel\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Prior testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with chest pain have undergone diagnostic testing for prior episodes, the results of which may be useful. As an example, a recent cardiac catheterization or coronary CT angiogram with normal or minimally diseased vessels virtually eliminates the possibility of an acute coronary syndrome (ACS). An observational study of 1977 consecutive patients with coronary arteriograms documenting minimal (ie, less than 25 percent) stenosis or normal coronary arteries found that 98 percent of these patients were free of myocardial infarction 10 years later [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/22\">",
"     22",
"    </a>",
"    ]. Other studies confirm this data [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/23\">",
"     23",
"    </a>",
"    ]. Conversely, a prior negative stress test is not useful to rule out ACS in patients with active chest pain in the ED.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most often the physical examination is not helpful in distinguishing patients with acute coronary syndromes (ACS) from those with noncardiac chest pain. In some instances, physical findings suggest a specific noncardiac diagnosis. Patients with an immediately life-threatening cause for their chest pain tend to appear anxious and distressed and may be diaphoretic and dyspneic.",
"   </p>",
"   <p>",
"    Physical examination findings in patients with aortic dissection may be absent or suggestive of other entities including stroke, myocardial infarction, and intraabdominal catastrophe, depending on the affected arteries. Discrepancies in pulses or blood pressure are notable findings. In the International Registry of Acute Aortic Dissection (IRAD), signs of dissection included: murmur of aortic insufficiency (32 percent) pulse deficit (15 percent), signs of shock or cardiac tamponade (8 percent), acute heart failure (7 percent), and cerebrovascular accident (5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/10\">",
"     10",
"    </a>",
"    ]. Up to 30 percent of patients may have neurologic findings.",
"   </p>",
"   <p>",
"    Chest pain associated with focal wheezing or asymmetric extremity swelling raises concern for pulmonary embolus (PE). Most often patients with PE have a normal extremity examination. Unilateral decreased breath sounds may be noted with pneumothorax; subcutaneous emphysema is uncommon.",
"   </p>",
"   <p>",
"    The presence of rales, with or without an S3 gallop, is associated with left ventricular dysfunction and left-sided heart failure, possibly due to ACS. Jugular venous distention, hepatojugular reflux, and peripheral edema suggest right-sided heart failure, possibly due to ACS or PE. A new systolic murmur is an ominous sign, which may signify papillary muscle dysfunction or a ventricular septal defect. Clinicians may hear a pericardial friction rub in patients with pericarditis. Hamman's crunch is a crackling sound similar to a pericardial friction rub heard over the mediastinum in patients with mediastinal emphysema.",
"   </p>",
"   <p>",
"    Epigastric tenderness and heme positive stool suggest a possible gastrointestinal source for pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute coronary syndrome &ndash; A standard 12-lead electrocardiogram (ECG) is obtained for all emergency department (ED) patients presenting with chest pain that may be from an acute coronary syndrome (ACS). Guidelines from the American College of Cardiology and American Heart Association",
"      <span class=\"nowrap\">",
"       (ACC/AHA)",
"      </span>",
"      suggest the ECG be obtained and interpreted within 10 minutes of patient presentation in the ED.",
"      <br/>",
"      <br/>",
"      Although the ECG remains the best immediately available test for detecting ACS, its sensitivity for acute myocardial infarction (AMI) is low. A single ECG performed during the patient's initial presentation detects fewer than 50 percent of AMIs. Patients with normal or nonspecific ECGs have a 1 to 5 percent incidence of AMI and a 4 to 23 percent incidence of unstable angina [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/24-28\">",
"       24-28",
"      </a>",
"      ]. The ECG should be repeated as frequently as every 10 minutes if the initial ECG is not diagnostic but the patient remains symptomatic and there remains high clinical suspicion for AMI. Prior ECGs are important for determining whether abnormalities are new. The presence of a left bundle branch block makes it difficult to determine the presence of ischemic ECG changes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      ECG interpretation in ACS is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link\">",
"       \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/26/4521?source=see_link\">",
"       \"Electrocardiogram in the prognosis of myocardial infarction or unstable angina\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary embolus &ndash; The ECG is of limited value in patients with pulmonary embolism (PE). The most common finding is sinus tachycardia. The classically described finding \"S1Q3T3\" (ie, prominent S wave in lead I, Q wave in lead III, and inverted T wave in lead III) reflects right heart strain but is neither sensitive nor specific for PE. Patients with acute PE rarely have a normal ECG, but a wide range of abnormalities is possible and most are equally likely to be seen in patients without PE [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/29\">",
"       29",
"      </a>",
"      ]. If the clinical scenario suggests PE, evidence of right heart strain further increases suspicion. Right axis deviation, right bundle branch block, right atrial enlargement (ie, \"P pulmonale\"), and atrial fibrillation can occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link&amp;anchor=H7#H7\">",
"       \"Diagnosis of acute pulmonary embolism\", section on 'Electrocardiography'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pericardial tamponade and pericarditis &ndash; ECG findings suggestive of tamponade include low voltage and electrical alternans. ECG findings in patients with pericarditis may mimic AMI and may vary as the disease progresses. Findings include PR segment depression, ST segment elevation, and T wave inversions. These findings are typically more diffuse than is found in patients with focal anatomic changes from myocardial ischemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=see_link&amp;anchor=H2297355#H2297355\">",
"       \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Electrocardiogram'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic dissection &ndash; The ECG tracing in aortic dissection can range from completely normal to ST segment elevation if the dissection involves the origin of a coronary artery. In the IRAD review of 464 patients with aortic dissection, the ECG was normal in 31 percent, showed nonspecific ST and T wave changes in 42 percent, and showed ischemic changes in 15 percent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\", section on 'Electrocardiogram'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac biomarkers &ndash; In the setting of acute myocardial infarction (AMI), common assays for cardiac troponin I detect elevations after approximately 6 hours, peak at 12 hours, and remain elevated for 7 to 10 days. Troponins are the preferred test for the diagnosis of AMI. Highly sensitive troponin assays become elevated more rapidly and elevations are even found in patients with what was classically considered to be unstable angina. Creatine kinase MB (CK-MB) isoform levels rise to twice normal at six hours and peak within approximately 24 hours.",
"      <br/>",
"      <br/>",
"      In the great majority of cases, a single set of negative cardiac biomarkers is",
"      <strong>",
"       NOT",
"      </strong>",
"      sufficient to rule out myocardial infarction. Patients with skeletal muscle disease, acute muscle exertion, chronic kidney disease, and cocaine use often have elevated levels of CK-MB in the absence of infarction. Troponin I has a higher specificity for myocardial necrosis than CK-MB in these patients. Negative initial cardiac biomarker determinations are not used to determine discharge. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31961?source=see_link&amp;anchor=H8#H8\">",
"       \"Evaluation of patients with chest pain at low or intermediate risk for acute coronary syndrome\", section on 'Cardiac biomarkers'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"       \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=see_link\">",
"       \"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      D-dimer &ndash; Among patients with a low-pretest probability for pulmonary embolus (PE), a D-dimer test with high sensitivity can rule out the diagnosis, obviating the need for further testing. The utility of the D-dimer test depends upon both patient baseline characteristics and the sensitivity and specificity of the test employed. Patients likely to have an elevated D-dimer at baseline are the elderly and those with malignancy, sepsis, recent major surgery or trauma, or pregnancy.",
"      <br/>",
"      <br/>",
"      Incorporating D-dimer results into decision-making for patients with possible PE requires knowledge of the diagnostic characteristics of the test employed and a predetermined algorithm for management in light of those results. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"       \"Diagnosis of acute pulmonary embolism\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      A d-dimer may be useful to rule out suspected aortic dissection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H766622465#H766622465\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\", section on 'D-dimer'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complete blood count &ndash; The white blood cell count may be elevated in any of the inflammatory or infectious etiologies of chest pain, such as myocarditis and pericarditis, mediastinitis, and pneumonia. Anemia in a patient with exertional chest pain is suggestive of myocardial ischemia.",
"     </li>",
"     <li>",
"      B-type natriuretic peptide (BNP) &ndash; A number of conditions can elevate the BNP, but levels above 100",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      have a 90 percent sensitivity for acute heart failure (HF) and levels below 50",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      have a 96 percent negative predictive value for HF [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/30\">",
"       30",
"      </a>",
"      ]. When used in conjunction with other clinical information, BNP can help to identify or exclude acute HF as the cause of dyspnea and chest pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"       \"Evaluation of the patient with suspected heart failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arterial blood gas &ndash; The arterial-alveolar oxygen gradient provides little help in diagnosing or excluding pulmonary embolism (PE), or in distinguishing PE from other causes of ventilation-perfusion mismatch. An arterial blood gas is not routinely indicated for patients with chest pain, even when pulmonary embolism is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link&amp;anchor=H4#H4\">",
"       \"Diagnosis of acute pulmonary embolism\", section on 'Arterial blood gas'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other tests &ndash; Several biomarkers, including smooth muscle myosin heavy chain, are being studied for use in early diagnosis of aortic dissection, but their role remains unclear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chest radiograph (CXR) is obtained in all chest pain patients with hemodynamic instability or a potentially life-threatening diagnosis. A nondiagnostic CXR is typical in patients with",
"    <strong>",
"     ACS",
"    </strong>",
"    .",
"   </p>",
"   <p>",
"    Approximately 90 percent of patients with",
"    <strong>",
"     aortic dissection",
"    </strong>",
"    will have some CXR abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/31\">",
"     31",
"    </a>",
"    ]. The classic findings of a widened mediastinum or aortic knob occur in up to 76 percent of patients. If clinical suspicion is high, these findings are associated with an odds ratio of 11 for aortic dissection (95% CI 6.1-19.8). Displacement of the aorta and pleural effusion may also be seen. Further imaging is obtained in nearly all patients with suspected aortic dissection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H21#H21\">",
"     \"Clinical manifestations and diagnosis of aortic dissection\", section on 'Chest radiograph'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The vast majority of patients with",
"    <strong>",
"     pulmonary embolus",
"    </strong>",
"    (PE) have a normal or nonspecific CXR. Nevertheless, several abnormalities may suggest this diagnosis, including: atelectasis, elevated hemidiaphragm, and pleural effusion. Classically described but rare findings include: pleural-based wedge-shaped defect (representing infarcted lung parenchyma, so-called Hampton's hump) or paucity of vascular markings distal to the site of embolus (Westermark's sign). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link&amp;anchor=H8#H8\">",
"     \"Diagnosis of acute pulmonary embolism\", section on 'Chest radiography'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pneumonia and pneumothorax are often diagnosed by CXR. A CXR taken with the patient in a lateral decubitus position may detect pneumothorax or pleural effusion when standard views are unrevealing. Acute heart failure is suggested by pulmonary vascular congestion and cardiomegaly. In patients with severe vomiting or recent instrumentation of the esophagus, mediastinal emphysema and pleural effusion suggest",
"    <strong>",
"     esophageal rupture",
"    </strong>",
"    . A hiatal hernia, pleural effusion, or mass may also explain patient symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\", section on 'Radiologic evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7544?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of acute decompensated heart failure\", section on 'Chest radiography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other imaging",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortic dissection &ndash; Several modalities diagnose aortic dissection with high sensitivity, including computed tomography (CT) (98 percent), magnetic resonance imaging (MRI) (98 percent), and transesophageal echocardiography (TEE) (94 percent).",
"      <br/>",
"      <br/>",
"      Availability and institutional expertise determine the modality used. TEE allows for rapid beside diagnosis of the hemodynamically unstable patient but requires an experienced echocardiographer. CT angiography is widely available in emergency departments (ED) and enables prompt diagnosis of aortic dissection, but may be contraindicated in patients with a contrast allergy or renal insufficiency. MRI may provide the greatest anatomic detail about the site of the intimal tear and branch vessel involvement, but it is not universally available in EDs, requires more time to perform than CT, and cannot accommodate patients with indwelling metallic hardware. Aortography was once the gold standard for diagnosis of aortic dissection but is now seldom used. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H20#H20\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary embolism &ndash; Pulmonary embolism (PE) can be diagnosed by computed tomography (CT), nuclear imaging, or pulmonary angiography. CT is the most widely used study for the diagnosis of PE. CT provides information about alternative etiologies of chest pain, but exposes patients to radiation and contrast dye, which can limit its use. Improved imaging with multidetector CT scanners allows for visualization of pulmonary emboli in the subsegmental pulmonary arteries, although smaller emboli are of questionable clinical significance. CT pulmonary angiography combined with venography can detect a deep vein thrombosis (DVT) using a single dose of contrast agent. Duplex ultrasonography can be helpful in patients at risk for PE with physical findings suggestive of DVT. Pulmonary angiography, once the gold standard, is rarely used. Nuclear",
"      <span class=\"nowrap\">",
"       ventilation/perfusion",
"      </span>",
"      lung scanning is still used, but frequently results in subsequent imaging because of the high number of indeterminant studies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link&amp;anchor=H2#H2\">",
"       \"Diagnosis of acute pulmonary embolism\", section on 'Diagnostic tests'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Computed tomography (CT) &ndash; Computed tomography (CT) technology continues to evolve. Studies for pulmonary embolism or aortic dissection can now be performed with a single injection of contrast. CT coronary angiography allows for quantification of coronary artery stenosis and studies suggest excellent correlation of CT coronary angiography with cardiac catheterization. CT can distinguish a pulmonary bleb from true pneumothorax and can determine the extent of mediastinal soilage in the setting of esophageal rupture. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=see_link\">",
"       \"Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nuclear cardiac imaging &ndash; Exercise stress testing has become commonplace in emergency departments (ED) with chest pain observation units. Exercise treadmill testing with or without nuclear imaging, as well as stress echocardiography, can assist in the risk stratification of ED patients with suspected acute coronary syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=see_link\">",
"       \"Stress testing for the diagnosis of coronary heart disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H28#H28\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Rest and stress imaging tests'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bedside Ultrasonography &ndash; Bedside ultrasonography is used with increasing frequency and expertise by emergency clinicians and often helps to exclude or support certain diagnoses. It is used to assess patients with blunt trauma as part of the extended FAST exam to identify traumatic pneumothorax. Bedside cardiac ultrasound can identify pericardial effusions and tamponade, wall motion abnormalities, valvular and septal abnormalities, right ventricular strain, and pleural effusions. However, echocardiography cannot distinguish old from new infarcts. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24342?source=see_link\">",
"       \"Transthoracic echocardiography for the evaluation of chest pain in the emergency department\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     APPROACH TO DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergency clinician assesses all patients with acute chest pain for life-threatening causes. Often a definitive diagnosis cannot be made initially and additional testing is performed in parallel with management. The patient's history, comorbidities, and description of symptoms help to narrow the scope of potential diagnoses and to stratify the patient's risk for life-threatening disease. The physical examination focuses on vital sign abnormalities and cardiac or pulmonary findings, and may support a diagnosis. An electrocardiogram (ECG) and chest x-ray (CXR) are reviewed. An algorithm outlining an approach to the emergency department patient with chest pain and a table allowing for quick comparison of findings in life-threatening causes of chest pain are provided (",
"    <a class=\"graphic graphic_algorithm graphicRef66425 \" href=\"UTD.htm?14/17/14612\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54629 \" href=\"UTD.htm?5/17/5406\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H5\">",
"     'History'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H13\">",
"     'Ancillary studies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute coronary syndrome &ndash; Acute coronary syndrome (ACS) is the most common potentially life-threatening cause of chest pain and is characterized by a paucity of examination findings. Any patient without a clear explanation for their chest pain after the initial workup, including electrocardiogram (ECG) and chest x-ray (CXR), is completed is assumed to have ACS until proven otherwise. Serial ECGs and formal risk assessment (eg, the TIMI score) are cornerstones of management [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. Patients with ST elevation myocardial infarction (STEMI) or at high risk for ACS are managed accordingly. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H3#H3\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Immediate ED interventions'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/31/37369?source=see_link\">",
"       \"Selecting a reperfusion strategy for acute ST elevation myocardial infarction\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Risk stratification of patients with potential ACS includes two parallel strategies: identify patients at such low risk that they can be safely discharged home with follow-up and identify patients at sufficiently high risk to require admission and acute management. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31961?source=see_link\">",
"       \"Evaluation of patients with chest pain at low or intermediate risk for acute coronary syndrome\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Keep the following guidance in mind when considering the diagnosis of ACS for a patient with acute chest pain. Assume that any patient who presents with symptoms of an acute coronary syndrome within a few days or weeks following percutaneous coronary interventions (eg, angioplasty or stent placement) or coronary artery bypass grafting has an abruptly occluded coronary artery or graft until proven otherwise. Remain cautious when assessing the elderly, diabetics, and women, who are more likely to manifest \"atypical\" symptoms with ACS. Never rely on a single ECG or a single set of cardiac biomarkers to rule out ACS, unless symptoms have been continuous and prolonged (ie, over six to eight hours). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H23#H23\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Disposition of patient without STEMI'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic dissection &ndash; According to one prospective observational study, the probability of aortic dissection increases significantly with the presence of the following findings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      History: Abrupt onset of thoracic or abdominal pain with a sharp, tearing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ripping character",
"     </li>",
"     <li>",
"      Examination: A variation in pulse (absence of a proximal extremity or carotid pulse)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      blood pressure (&gt;20 mmHg difference between the right and left arm)",
"     </li>",
"     <li>",
"      Chest radiograph (CXR): Mediastinal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      aortic widening [",
"      <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/31\">",
"       31",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The emergency clinician should look for these examination and radiographic findings in any patient with a history suggestive of aortic dissection. According to this study, aortic dissection occurs in approximately 83 percent of patients with classic aortic dissection pain and suggestive CXR findings, and approximately 92 percent of patients with classic pain and an absent pulse or significant difference in blood pressure. When all three variables coexist, aortic dissection is present in all patients. When no variables are present approximately 7 percent of patients have aortic dissection. Definitive diagnostic testing is determined by the patient's hemodynamic stability and the imaging modalities available. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical manifestations and diagnosis of aortic dissection\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary embolism &ndash; Pulmonary embolism (PE) is a common and potentially life-threatening disease frequently missed by emergency clinicians because of its wide range of presentations and nonspecific findings on examination, electrocardiogram, and chest x-ray. Often the biggest problem with PE is failure to consider the diagnosis. Emergency clinicians must consider PE a potential diagnosis in any patient with acute chest discomfort or dyspnea who lacks a firm alternative diagnosis (eg, myocardial infarction diagnosed by history and elevated ST segments, pericardial tamponade diagnosed by ultrasound).",
"      <br/>",
"      <br/>",
"      The approach to patients with potential PE focuses on risk stratification. Patients with symptoms suggestive of PE and right ventricular heart dysfunction or hemodynamic instability are at high risk and may benefit from emergent thrombolysis or embolectomy. For all other patients, risk stratification depends on the pretest probability for PE.",
"      <br/>",
"      <br/>",
"      Several scoring systems exist to characterize patient risk for PE, including the Wells score, the Charlotte criteria, the revised Geneva score, and the PERC rule. For patients at low-clinical risk it is generally reasonable to withhold anticoagulant therapy while a D-dimer test is performed. In patients at low risk, PE can be ruled out with a negative D-dimer test, provided the test is of high sensitivity. Patients at low risk but whose D-dimer test is positive and those at higher risk require further testing. The PERC rule identifies patients at sufficiently low risk for PE that even D-dimer testing may be unnecessary. Detailed discussions of risk stratification, diagnosis, and management are found separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=see_link&amp;anchor=H13#H13\">",
"       \"Overview of acute pulmonary embolism\", section on 'Symptoms / Signs'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"       \"Diagnosis of acute pulmonary embolism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=see_link\">",
"       \"Treatment of acute pulmonary embolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pericardial tamponade &ndash; Bedside ultrasound is an ideal tool to diagnose or rule out cardiac tamponade in any patient with suggestive historical, examination, or electrocardiogram findings. ED clinicians should perform this study in every patient with acute chest pain and signs of shock. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"       \"Cardiac tamponade\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumothorax &ndash; Tension pneumothorax is diagnosed clinically and treated with immediate needle thoracostomy, followed by tube thoracostomy. A suggestive history combined with hemodynamic compromise and unilateral diminished breath sounds is the usual presentation. Treatment should not be delayed for confirmation by chest x-ray (CXR). A CXR or bedside ultrasound may be used to make the diagnosis in patients without signs of tension. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"       \"Primary spontaneous pneumothorax in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mediastinitis &ndash; The initial plain chest radiograph is almost always abnormal in patients with esophageal perforation and mediastinitis, and usually reveals mediastinal or free peritoneal air as the initial radiologic manifestation. CT scan may show extraesophageal air, periesophageal fluid, mediastinal widening, and air and fluid in the pleural spaces, retroperitoneum or lesser sac. The diagnosis is confirmed with the oral administration of a water soluble contrast agent followed by chest radiography looking for extravasation of contrast. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link&amp;anchor=H3#H3\">",
"       \"Boerhaave's syndrome: Effort rupture of the esophagus\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the chest pain patient in the emergency department (ED) begins with assessment and stabilization of the airway, breathing, and circulation. Life-threatening problems are treated immediately, without delay for confirmatory testing. Any patient with acute chest pain at risk for a life-threatening disease is placed on a cardiac monitor and given oxygen while intravenous access is established. An electrocardiogram (ECG) and chest x-ray (CXR) are obtained.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute coronary syndrome &ndash; Management of acute coronary syndrome (ACS) is determined largely by electrocardiogram (ECG) findings. Serial ECGs dramatically increase the sensitivity for detecting ACS, compared with a single initial ECG. Patients with ST elevation myocardial infarction (STEMI) require emergent revascularization via percutaneous intervention or fibrinolysis. The management of ACS is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H3#H3\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Immediate ED interventions'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/31/37369?source=see_link\">",
"       \"Selecting a reperfusion strategy for acute ST elevation myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=see_link\">",
"       \"Overview of the acute management of ST elevation myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=see_link\">",
"       \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic dissection &ndash; Emergent treatment for a suspected aortic dissection involves blood pressure and heart rate control to reduce shearing forces and intensity of pulsatile cardiac flow. This is best achieved via a combination of beta blockers (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40536?source=see_link\">",
"       esmolol",
"      </a>",
"      ) and sodium",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"       nitroprusside",
"      </a>",
"      (or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"       nitroglycerin",
"      </a>",
"      ). Beta blockers should be started first to prevent potential rebound tachycardia associated with the vasodilatory effects of sodium nitroprusside.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"       Labetalol",
"      </a>",
"      , which has both beta and alpha blocking effects, can also be used to manage blood pressure. Emergent imaging and cardiothoracic surgery consultation is obtained. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25449?source=see_link\">",
"       \"Management of aortic dissection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary embolus &ndash; Initial management for confirmed pulmonary embolus involves anticoagulation. There is no evidence demonstrating that empiric anticoagulation should be initiated before test results are obtained. Patients with massive or submassive emboli may require more aggressive therapy with thrombolytics or embolectomy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=see_link\">",
"       \"Treatment of acute pulmonary embolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumothorax &ndash; Tension pneumothorax is treated with immediate tube thoracostomy or immediate needle thoracostomy followed by tube thoracostomy. Treatment should not be delayed for confirmation by chest x-ray (CXR). Symptomatic pneumothoraces not under tension are treated most often with tube thoracostomy, but smaller pneumothoraces may be amenable to aspiration and observation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"       \"Primary spontaneous pneumothorax in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"       \"Placement and management of thoracostomy tubes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pericardial tamponade &ndash; Tamponade with overt hemodynamic compromise requires emergent removal of pericardial fluid, which produces a rapid and dramatic improvement in cardiac and systemic hemodynamics. Early tamponade with only mild hemodynamic compromise may be treated conservatively, with careful monitoring, serial echocardiographic studies, avoidance of volume depletion, and therapy aimed at the underlying cause. The decision to drain an effusion must take into account the clinical assessment, echocardiographic findings, and the risk of the procedure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link&amp;anchor=H26#H26\">",
"       \"Cardiac tamponade\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mediastinitis &ndash; Broad spectrum antibiotics are given early in suspected mediastinitis. Consultation with cardiothoracic surgery is obtained for surgical debridement and possible repair. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link&amp;anchor=H4#H4\">",
"       \"Boerhaave's syndrome: Effort rupture of the esophagus\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     DISPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any patient with hemodynamic instability or significant respiratory distress is admitted to the intensive care unit (ICU). Patients with aortic dissection, pneumothorax, cardiac tamponade, and mediastinitis require admission and appropriate consultation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25449?source=see_link\">",
"     \"Management of aortic dissection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"     \"Primary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link\">",
"     \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Patients with pulmonary emboli with hemodynamic instability or significant hypoxia are admitted to the ICU. Stable patients with pulmonary embolism do not require admission to an ICU or telemetry monitoring. Some low-risk patients may even be treated as an outpatient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=see_link\">",
"     \"Treatment of acute pulmonary embolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with STEMI receive reperfusion therapy via fibrinolytics or percutaneous coronary intervention and are admitted to the ICU. Patients at high risk for acute coronary syndrome (ACS) or death are admitted to an ICU; patients at moderate risk are admitted to a non-ICU monitored setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/31/37369?source=see_link\">",
"     \"Selecting a reperfusion strategy for acute ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=see_link\">",
"     \"Overview of the acute management of unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients not at low risk for ACS but without known coronary artery disease or obvious signs of myocardial infarction but no clear alternative diagnosis are admitted to rule out myocardial ischemia with serial cardiac biomarkers, electrocardiograms (ECG) testing, and possibly further testing. Patients at low risk with normal ECGs are managed in a non-ICU monitored setting, floor bed, or a chest pain observation unit. Exercise treadmill or pharmacological testing with or without nuclear imaging, as well as stress echocardiography and CT coronary angiography, can assist cardiovascular risk stratification in the ED. Patients with an uneventful observation period, negative serial cardiac markers, and a normal stress test can be safely discharged with a referral for follow-up. If released without provocative testing, low-risk patients should have clear follow-up arranged, ideally within a few days of discharge. Follow-up within 72 hours is safe [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31961?source=see_link\">",
"     \"Evaluation of patients with chest pain at low or intermediate risk for acute coronary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=see_link\">",
"     \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=see_link\">",
"     \"Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with",
"    <strong>",
"     stable",
"    </strong>",
"    angina do not require inpatient evaluation. Patients less than 40 years old with normal ECGs and no prior cardiac history have less than a one percent risk of ACS and less than a one percent risk of death, acute myocardial infarction, or revascularization at 30 days [",
"    <a class=\"abstract\" href=\"UTD.htm?19/39/20090/abstract/35\">",
"     35",
"    </a>",
"    ]. They can be discharged to home with follow-up.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21276208\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chest pain accounts for a large number of emergency department (ED) visits. Patients present with a spectrum of signs and symptoms reflecting the many potential etiologies of chest pain. Diseases of the heart, aorta, lungs, esophagus, stomach, mediastinum, pleura, and abdominal viscera may all cause chest discomfort.",
"     </li>",
"     <li>",
"      Clinicians in the ED focus on the immediate recognition and exclusion of life-threatening causes of chest pain. Patients with life threatening etiologies for chest pain may appear deceptively well, manifesting neither vital sign nor physical examination abnormalities.",
"     </li>",
"     <li>",
"      Causes of chest pain that pose an immediate threat to life include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acute coronary syndrome (ACS)",
"     </li>",
"     <li>",
"      Aortic dissection",
"     </li>",
"     <li>",
"      Pulmonary embolism",
"     </li>",
"     <li>",
"      Tension pneumothorax",
"     </li>",
"     <li>",
"      Pericardial tamponade",
"     </li>",
"     <li>",
"      Mediastinitis (eg, Esophageal rupture) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Differential diagnosis'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Significant overlap exists among the symptoms experienced by patients with life-threatening and common causes of chest pain. Patient descriptions of their symptoms can be helpful in some instances, but emergency clinicians must guard against premature diagnostic closure based upon history. So-called \"atypical\" presentations occur often; misinterpretation of such presentations increases the risk for adverse outcomes. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination is often not helpful in distinguishing ACS from noncardiac chest pain. In some instances, physical findings suggest a specific noncardiac diagnosis. Patients with an immediately life-threatening cause for their chest pain tend to appear anxious and distressed and may be diaphoretic and dyspneic. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Commonly obtained tests and studies used to help differentiate the cause of chest pain are described in the text. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Ancillary studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A basic approach to the diagnosis and management of patients with potentially life-threatening causes of chest pain is provided in the text, along with links to more detailed discussions. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Approach to diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Disposition'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     McCaig, L, Burt, C. National Hospital Ambulatory Medical Care Survey: 2003 Emergency Department Summary. In: Advance Data from Vital and Health Statistics. Centers for disease control and prevention, Atlanta, GA 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/2\">",
"      Launbjerg J, Fruergaard P, Hesse B, et al. Long-term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. Cardiology 1996; 87:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/3\">",
"      Lindsell CJ, Anantharaman V, Diercks D, et al. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 2006; 48:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/4\">",
"      Estrera AS, Landay MJ, Grisham JM, et al. Descending necrotizing mediastinitis. Surg Gynecol Obstet 1983; 157:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/5\">",
"      Burnett CM, Rosemurgy AS, Pfeiffer EA. Life-threatening acute posterior mediastinitis due to esophageal perforation. Ann Thorac Surg 1990; 49:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/6\">",
"      Sancho LM, Minamoto H, Fernandez A, et al. Descending necrotizing mediastinitis: a retrospective surgical experience. Eur J Cardiothorac Surg 1999; 16:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/7\">",
"      Makeieff M, Gresillon N, Berthet JP, et al. Management of descending necrotizing mediastinitis. Laryngoscope 2004; 114:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/8\">",
"      Gupta M, Tabas JA, Kohn MA. Presenting complaint among patients with myocardial infarction who present to an urban, public hospital emergency department. Ann Emerg Med 2002; 40:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/9\">",
"      Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/10\">",
"      Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000; 283:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/11\">",
"      Ringstrom E, Freedman J. Approach to undifferentiated chest pain in the emergency department: a review of recent medical literature and published practice guidelines. Mt Sinai J Med 2006; 73:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/12\">",
"      Jagminas L, Silverman RA. Boerhaave's syndrome presenting with abdominal pain and right hydropneumothorax. Am J Emerg Med 1996; 14:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/13\">",
"      Brauer RB, Liebermann-Meffert D, Stein HJ, et al. Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus 1997; 10:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/14\">",
"      Shry EA, Dacus J, Van De Graaff E, et al. Usefulness of the response to sublingual nitroglycerin as a predictor of ischemic chest pain in the emergency department. Am J Cardiol 2002; 90:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/15\">",
"      Grailey K, Glasziou PP. Diagnostic accuracy of nitroglycerine as a 'test of treatment' for cardiac chest pain: a systematic review. Emerg Med J 2012; 29:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/16\">",
"      Klompas M. Does this patient have an acute thoracic aortic dissection? JAMA 2002; 287:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/17\">",
"      Goodacre S, Locker T, Morris F, Campbell S. How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? Acad Emerg Med 2002; 9:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/18\">",
"      Khan IA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002; 122:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/19\">",
"      Jayes RL Jr, Beshansky JR, D'Agostino RB, Selker HP. Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. J Clin Epidemiol 1992; 45:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/20\">",
"      Joseph J, Sahn SA. Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med 1996; 100:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/21\">",
"      Henry M, Arnold T, Harvey J, Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of spontaneous pneumothorax. Thorax 2003; 58 Suppl 2:ii39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/22\">",
"      Papanicolaou MN, Califf RM, Hlatky MA, et al. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol 1986; 58:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/23\">",
"      Pitts WR, Lange RA, Cigarroa JE, Hillis LD. Repeat coronary angiography in patients with chest pain and previously normal coronary angiogram. Am J Cardiol 1997; 80:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/24\">",
"      Brush JE Jr, Brand DA, Acampora D, et al. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med 1985; 312:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/25\">",
"      Slater DK, Hlatky MA, Mark DB, et al. Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. Am J Cardiol 1987; 60:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/26\">",
"      Lee TH, Cook EF, Weisberg M, et al. Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med 1985; 145:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/27\">",
"      Selker HP, Zalenski RJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med 1997; 29:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/28\">",
"      Hathaway WR, Peterson ED, Wagner GS, et al. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA 1998; 279:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/29\">",
"      Rodger M, Makropoulos D, Turek M, et al. Diagnostic value of the electrocardiogram in suspected pulmonary embolism. Am J Cardiol 2000; 86:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/30\">",
"      Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/31\">",
"      von Kodolitsch Y, Schwartz AG, Nienaber CA. Clinical prediction of acute aortic dissection. Arch Intern Med 2000; 160:2977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/32\">",
"      Chase M, Robey JL, Zogby KE, et al. Prospective validation of the Thrombolysis in Myocardial Infarction Risk Score in the emergency department chest pain population. Ann Emerg Med 2006; 48:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/33\">",
"      Lee B, Chang AM, Matsuura AC, et al. Comparison of cardiac risk scores in ED patients with potential acute coronary syndrome. Crit Pathw Cardiol 2011; 10:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/34\">",
"      Meyer MC, Mooney RP, Sekera AK. A critical pathway for patients with acute chest pain and low risk for short-term adverse cardiac events: role of outpatient stress testing. Ann Emerg Med 2006; 47:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/39/20090/abstract/35\">",
"      Walker NJ, Sites FD, Shofer FS, Hollander JE. Characteristics and outcomes of young adults who present to the emergency department with chest pain. Acad Emerg Med 2001; 8:703.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 288 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-4F64B2DDF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20090=[""].join("\n");
var outline_f19_39_20090=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21276208\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Common conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Onset of pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pain quality and location",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Associated symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Prior testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      APPROACH TO DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      DISPOSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21276208\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/288\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/288|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?14/17/14612\" title=\"algorithm 1\">",
"      Chest pain ED approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/288|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/58/37803\" title=\"table 1\">",
"      Aortic dissection anatomy based clinical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/17/5406\" title=\"table 2\">",
"      Chest pain differentiation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=related_link\">",
"      Boerhaave's syndrome: Effort rupture of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=related_link\">",
"      Chest pain of esophageal origin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=related_link\">",
"      Clinical manifestations and diagnosis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/19/25914?source=related_link\">",
"      Clinical manifestations and diagnosis of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=related_link\">",
"      Clinical presentation and diagnostic evaluation of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4633?source=related_link\">",
"      Complications of scuba diving",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/17/36119?source=related_link\">",
"      Cor pulmonale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/0/26634?source=related_link\">",
"      Differential diagnosis of chest pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=related_link\">",
"      Electrocardiogram in the diagnosis of myocardial ischemia and infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/26/4521?source=related_link\">",
"      Electrocardiogram in the prognosis of myocardial infarction or unstable angina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/30/2537?source=related_link\">",
"      Elevated cardiac troponin concentration in the absence of an acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44361?source=related_link\">",
"      Epidemiology of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/23/7544?source=related_link\">",
"      Evaluation of acute decompensated heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/13/31961?source=related_link\">",
"      Evaluation of patients with chest pain at low or intermediate risk for acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2201?source=related_link\">",
"      Major causes of musculoskeletal chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/54/25449?source=related_link\">",
"      Management of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3476?source=related_link\">",
"      Mitral valve prolapse syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=related_link\">",
"      Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/22/4456?source=related_link\">",
"      Overview of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37193?source=related_link\">",
"      Overview of the acute management of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=related_link\">",
"      Overview of the care of patients with stable ischemic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7305?source=related_link\">",
"      Pharmacotherapy for panic disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35271?source=related_link\">",
"      Pneumothorax and air travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20678?source=related_link\">",
"      Pneumothorax in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/6/21608?source=related_link\">",
"      Postherpetic neuralgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=related_link\">",
"      Primary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=related_link\">",
"      Secondary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/31/37369?source=related_link\">",
"      Selecting a reperfusion strategy for acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=related_link\">",
"      Stress echocardiography in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=related_link\">",
"      Stress testing for the diagnosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4167?source=related_link\">",
"      The role of platelets in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24342?source=related_link\">",
"      Transthoracic echocardiography for the evaluation of chest pain in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/56/5002?source=related_link\">",
"      Treatment of acute exacerbations of asthma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42503?source=related_link\">",
"      Treatment of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_39_20091="Causes of seizures in older patients";
var content_f19_39_20091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F76342&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F76342&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of seizures and epilepsy in elderly patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Relative proportion, percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Acute seizures",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Acute stroke",
"      </td>",
"      <td>",
"       50",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Metabolic encephalopathy",
"      </td>",
"      <td>",
"       6-30",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Drugs",
"      </td>",
"      <td>",
"       10",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Others (trauma, infections)",
"      </td>",
"      <td>",
"       5-20",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Epilepsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cerebrovascular disease",
"      </td>",
"      <td>",
"       30-50",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dementia",
"      </td>",
"      <td>",
"       9-17",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Others (tumors, trauma)",
"      </td>",
"      <td>",
"       5-15",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cryptogenic",
"      </td>",
"      <td>",
"       30-50",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20091=[""].join("\n");
var outline_f19_39_20091=null;
var title_f19_39_20092="Atypical mole syndrome";
var content_f19_39_20092=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Atypical mole syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Sporadic syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Atypical mole syndrome",
"       </td>",
"       <td>",
"        Three or more of the following characteristics:",
"        <ol>",
"         <li>",
"          Two or more clinically atypical nevi",
"         </li>",
"         <li>",
"          &gt;100 nevi &gt;2 mm diameter or &gt;50 nevi if &lt;20 or &gt;50 years of age",
"         </li>",
"         <li>",
"          Nevi abnormally distributed (buttocks or dorsum of foot)",
"         </li>",
"         <li>",
"          Nevi in the anterior scalp",
"         </li>",
"         <li>",
"          Iris pigmented lesion(s)",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Classical atypical mole syndrome",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          &gt;100 melanocytic nevi",
"         </li>",
"         <li>",
"          One or more nevi &gt;8 mm diameter",
"         </li>",
"         <li>",
"          One or more nevi with atypical features",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        B-K mole",
"       </td>",
"       <td>",
"        &ge;10 mm diameter; irregular outline; haphazard mixture of tan, brown, black, and pink; small palpable dermal component",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        B-K mole syndrome",
"       </td>",
"       <td>",
"        Fewer than 10 B-K moles to more than 100 moles prominent on the upper trunk and extremities; variability of mole size (5 to 15 mm diameter), outline, and color",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Familial syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Familial atypical mole syndrome",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Two or more family members with atypical moles",
"         </li>",
"         <li>",
"          One or more family members with melanoma",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Familial atypical multiple mole melanoma syndrome",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Melanoma in two or more first- or second-degree relatives",
"         </li>",
"         <li>",
"          Many atypical nevi (often more than 50)",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Marghoob AA, Kovalyshyn I, Halpern AC. Management of Dysplastic Nevi and Melonomas. In: Surgery of the Skin, 2nd ed, Robinson JK (Ed), Elsevier 2010. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20092=[""].join("\n");
var outline_f19_39_20092=null;
var title_f19_39_20093="Thyroid hormones preterm";
var content_f19_39_20093=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Concentrations of free T4, T4, T3, and TSH in preterm and term infants, in cord blood at birth and at 7, 14, and 28 days of age (mean &plusmn; 1 SD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Gestation (weeks)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age of specimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Free T4 (ng/dL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        T4 (microgram/dL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        T3 (ng/dL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        TSH (mU/L)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"4\">",
"        23-27 weeks",
"       </td>",
"       <td>",
"        Cord",
"       </td>",
"       <td>",
"        1.28 &plusmn; 0.4",
"       </td>",
"       <td>",
"        5.4 &plusmn; 2.0",
"       </td>",
"       <td>",
"        20 &plusmn; 15",
"       </td>",
"       <td>",
"        6.8 &plusmn; 2.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 d",
"       </td>",
"       <td>",
"        1.47 &plusmn; 0.6",
"       </td>",
"       <td>",
"        4.0 &plusmn; 1.8",
"       </td>",
"       <td>",
"        33 &plusmn; 20",
"       </td>",
"       <td>",
"        3.5 &plusmn; 2.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14 d",
"       </td>",
"       <td>",
"        1.45 &plusmn; 0.5",
"       </td>",
"       <td>",
"        4.7 &plusmn; 2.6",
"       </td>",
"       <td>",
"        41 &plusmn; 25",
"       </td>",
"       <td>",
"        3.9 &plusmn; 2.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28 d",
"       </td>",
"       <td>",
"        1.50 &plusmn; 0.4",
"       </td>",
"       <td>",
"        6.1 &plusmn; 2.3",
"       </td>",
"       <td>",
"        63 &plusmn; 27",
"       </td>",
"       <td>",
"        3.8 &plusmn; 4.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"4\">",
"        28-30 weeks",
"       </td>",
"       <td>",
"        Cord",
"       </td>",
"       <td>",
"        1.45 &plusmn; 0.4",
"       </td>",
"       <td>",
"        6.3 &plusmn; 2.0",
"       </td>",
"       <td>",
"        29 &plusmn; 21",
"       </td>",
"       <td>",
"        7.0 &plusmn; 3.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 d",
"       </td>",
"       <td>",
"        1.82 &plusmn; 0.7",
"       </td>",
"       <td>",
"        6.3 &plusmn; 2.1",
"       </td>",
"       <td>",
"        56 &plusmn; 24",
"       </td>",
"       <td>",
"        3.6 &plusmn; 2.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14 d",
"       </td>",
"       <td>",
"        1.65 &plusmn; 0.4",
"       </td>",
"       <td>",
"        6.6 &plusmn; 2.3",
"       </td>",
"       <td>",
"        72 &plusmn; 28",
"       </td>",
"       <td>",
"        4.9 &plusmn; 11.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28 d",
"       </td>",
"       <td>",
"        1.71 &plusmn; 0.4",
"       </td>",
"       <td>",
"        7.5 &plusmn; 2.3",
"       </td>",
"       <td>",
"        87 &plusmn; 31",
"       </td>",
"       <td>",
"        3.6 &plusmn; 2.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"4\">",
"        31-34 weeks",
"       </td>",
"       <td>",
"        Cord",
"       </td>",
"       <td>",
"        1.49 &plusmn; 0.3",
"       </td>",
"       <td>",
"        7.6 &plusmn; 2.3",
"       </td>",
"       <td>",
"        35 &plusmn; 23",
"       </td>",
"       <td>",
"        7.9 &plusmn; 5.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 d",
"       </td>",
"       <td>",
"        2.14 &plusmn; 0.6",
"       </td>",
"       <td>",
"        9.4 &plusmn; 3.4",
"       </td>",
"       <td>",
"        92 &plusmn; 36",
"       </td>",
"       <td>",
"        3.6 &plusmn; 4.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14 d",
"       </td>",
"       <td>",
"        1.98 &plusmn; 0.4",
"       </td>",
"       <td>",
"        9.1 &plusmn; 3.6",
"       </td>",
"       <td>",
"        110 &plusmn; 41",
"       </td>",
"       <td>",
"        3.8 &plusmn; 9.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28 d",
"       </td>",
"       <td>",
"        1.88 &plusmn; 0.5",
"       </td>",
"       <td>",
"        8.9 &plusmn; 3.0",
"       </td>",
"       <td>",
"        120 &plusmn; 40",
"       </td>",
"       <td>",
"        3.5 &plusmn; 3.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"4\">",
"        &ge;37 weeks",
"       </td>",
"       <td>",
"        Cord",
"       </td>",
"       <td>",
"        1.41 &plusmn; 0.3",
"       </td>",
"       <td>",
"        9.2 &plusmn; 1.9",
"       </td>",
"       <td>",
"        60 &plusmn; 35",
"       </td>",
"       <td>",
"        6.7 &plusmn; 4.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 d",
"       </td>",
"       <td>",
"        2.70 &plusmn; 0.6",
"       </td>",
"       <td>",
"        12.7 &plusmn; 2.9",
"       </td>",
"       <td>",
"        148 &plusmn; 50",
"       </td>",
"       <td>",
"        2.6 &plusmn; 1.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14 d",
"       </td>",
"       <td>",
"        2.03 &plusmn; 0.3",
"       </td>",
"       <td>",
"        10.7 &plusmn; 1.4",
"       </td>",
"       <td>",
"        167 &plusmn; 31",
"       </td>",
"       <td>",
"        2.5 &plusmn; 2.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28 d",
"       </td>",
"       <td>",
"        1.65 &plusmn; 0.3",
"       </td>",
"       <td>",
"        9.7 &plusmn; 2.2",
"       </td>",
"       <td>",
"        176 &plusmn; 32",
"       </td>",
"       <td>",
"        1.8 &plusmn; 0.9",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Williams FL, Simpson J, Delahunty C, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004; 89:5314.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20093=[""].join("\n");
var outline_f19_39_20093=null;
var title_f19_39_20094="Glucose level during prolonged exercise pregnant vs nonpregnant";
var content_f19_39_20094=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    Glucose concentrations during prolonged exercise: pregnant versus nonpregnant.",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 377px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * P &lt;.05.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Soultanakis, HN, Artal, R, Wiswell, RA. Prolonged exercise in pregnancy: glucose homeostasis, ventilatory, and cardiovascular responses. Semin Perinatol 1996; 20:315. Copyright &copy;1996 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20094=[""].join("\n");
var outline_f19_39_20094=null;
var title_f19_39_20095="Med bronchogen cyst CT IV";
var content_f19_39_20095=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53262&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53262&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right paratracheal bronchogenic cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 265px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan shows a low attenuation, non-enhancing cyst.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_39_20095=[""].join("\n");
var outline_f19_39_20095=null;
